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Previous studies from this lab have determined that dedifferentiation of Müller glia
(MG) occurs after application of an α7 nicotinic acetylcholine receptor agonist, PNU-282987
(PNU), to retinal pigment epithelial (RPE) cells in adult rodents. This study was designed to
explore the role of the HB-EGF/Ascl1/Lin28a signaling pathway in MG dedifferentiation to
retinal progenitor cells. RNAseq was performed on MG following contact with RPE-J cells
treated with PNU-282987. Up- or down-regulated genes were compared with published
literature of MG dedifferentiation that occurs in lower vertebrate regeneration or with
transcript profiles during early mammalian development. Between 8-12 hours, up-regulation
was observed in gene HB-EGF and after 48 hours, up-regulation was found in Ascl1 and Lin28a,
known to be rapidly induced in de-differentiating MG in zebrafish. Up-regulation was found in
other factors known to be involved in mammalian development and zebrafish regeneration,
and down-regulation in some factors necessary for MG differentiation. RNA-seq results were
verified using qRT-PCR. Using immunocytochemistry, we were able to confirm the presence of
retinal progenitor markers OTX2, Nestin and VSX2 in MG 48 hours post treatment with PNUtreated RPE supernatant. The results from this study will further our understanding of adult
mammalian neurogenesis, will lead to new insights into typical mammalian neurogenesis
limitations and provide potential strategies to treat neurodegenerative diseases.
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CHAPTER I
INTRODUCTION

1.1 Hypothesis
Stimulation of the α7 nAChR in adult mice retinal pigment epithelium induces the HBEGF/Ascl1/Lin28a pathway in Müller glia to drive cellular dedifferentiation to retinal progenitor
cells.
Neurodegenerative diseases of the retina such as glaucoma, macular degeneration,
retinal ischemia and diabetic retinopathy lead to irreversible loss of retinal cells in adult
mammals (Velez-Montoya, et al., 2013; Weinreb, et al., 2014; Duh, et al., 2017; Dattilo, et al.,
2018). However, within the mammalian neuronal retina, neurogenesis does not typically occur
after early development (Dhomen, et al., 2006; Lamba, et al., 2006; Centanin, et al., 2014). The
retina is characterized as a part of the central nervous system, despite its peripheral location,
because it originates as an outgrowth of the embryonic diencephalon (Agranoff, et al., 1980;
Purves, et al., 2001; London, et al., 2013). Decades of research has been performed in an effort
to understand the inability of mammals to regenerate the central nervous system as adults,
given the fact that other animals are able to do so throughout adulthood. It is thought that the
mechanism by which central nervous system regeneration occurs exists within mammals but
has been inhibited through evolutionary time (Chen, et al., 1998; Nicholls, et al., 1999; Tanaka,
et al., 2009; Echeverri, 2020).
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Previous research indicates neuroprotective or neurotrophic effects of alpha 7 nicotinic
acetylcholine receptor (α7 nAChR) agonists after activation of α7 nAChRs (Mudo, et al., 2007;
Asomugha, et al., 2010; Iwamoto, et al., 2013). In the retina, neuroprotection or neurogenesis
occurs depending on stimulation of neuronal or non-neuronal α7 nAChRs. When neuronal α7
nAChRs are stimulated in the retina, multiple studies have shown that α7 nAChR activation of
retinal ganglion cells (RGCs) is neuroprotective against glutamate-induced cytotoxicity
(Wehrwein, et al., 2004; Asomugha, et al., 2010; Iwamoto, et al., 2013; Iwamoto, et al., 2014).
This occurs due to the selective α7 nAChR agonist, PNU-282987. PNU-282987 has also been
shown to prevent the loss of RGCs by over 25% in an induced glaucoma model (Iwamoto, et al.,
2014). Use of α7 nAChR agonists has demonstrated neuroprotective capabilities in other
systems as well. The α7 nAChR is one of the most abundant nAChR subtypes in the brain
(Graham, et al., 2003; Fan, et al., 2014). This receptor is significantly reduced in patients with
Alzheimer’s disease and is thought to interact with Aβ amyloid, a peptide believed to drive the
pathogenesis of Alzheimer’s disease forward (Murphy, et al., 2010; Fan, et al., 2014). The
complex formed by α7 nAChRs and Aβ amyloid has been shown to lead to disruption of the
cholinergic phenotype, synaptic plasticity, and, eventually, cognitive dysfunction (Hoskin, et al.,
2019). Administration of α7 nAChR agonists such as Encenicline, ABT-418, and WAY-317538
show improvement in memory and other cognitive deficits in Alzheimer’s disease patients
(Decker, et al., 1994; Potter, et al., 1999; Hoskin, et al., 2019). PNU-282987 was demonstrated
in mice to protect the mouse brain from inflammation produced in Alzheimer’s disease models
and restore memory function (Lykhmus, et al., 2020).
In response to stimulation of non-neuronal α7 nAChRs in the retinal pigment epithelium
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(RPE), neurogenesis in adult mammals has been demonstrated (Webster et al., 2017; 2019).
Previous work from this lab indicated that administration of the α7 nAChR-specific agonist via
eyedrops to adult mouse and rat eyes is capable of inducing cell cycle reentry of Müller glial
cells in the inner nuclear layer of the adult mammalian retina (Webster, et al., 2017; 2019).
When PNU-282987 is applied as eye drops, Müller glia cell bodies proliferate and migrate
through retinal layers and eventually toward the ganglion cell layer of the retina (Webster, et
al., 2017). This observed interkinetic nuclear migration is consistent with regenerative
capacities in developing mice (Tackenberg, et al., 2009; Webster, et al., 2017). Cell cycle reentry
was indicated by the presence of 5-bromo-2’-deoxyuridine (BrdU) positive cells. BrdU is a
thymine analogue which incorporates into the genome of cells entering the S phase of mitosis.
The source of BrdU positive cells was shown to be the Müller glia in experiments where Müller
glia and BrdU positive cells were double labeled using immunohistochemistry, as well as in
experiments with transgenic mice in which TdTomato Müller glia co-labeled migrating BrdU+
cells (Webster, et al., 2017; 2019).
Dedifferentiation of Muller glia is a mechanism consistent with regeneration of the
retina in adult zebrafish following injury. In zebrafish, the HB-EGF/Ascl1/Lin28a pathway is
crucial in retinal regeneration following injury (Wan, et al., 2012). HB-EGF is one of many ligands
which activate EGF receptors (Wan, et al., 2012). HB-EGF is found at the injury site of the
injured zebrafish retina. HB-EGF activates the regeneration-associated gene Ascl1, which has
been shown to modulate histone binding involved in neuronal stem cell dedifferentiation
(Vierbuchen, et al., 2010). Ascl1 activates RNA binding protein Lin28a, which is known to inhibit
microRNA Let-7 (Yao, et al., 2016). Let-7 is involved in inhibition of proliferative abilities in adult
Müller glia in zebrafish (Yao, et al., 2016). When Let-7 is inhibited, the Wnt pathway moves
3

forward to allow for dedifferentiation of Müller glia to produce retinal progenitor cells (Yao, et
al., 2016).
However, Müller glia, the source of proliferation following administration of PNU282987
in adult mice and rats, do not contain α7 nAChRs (Dmitrieva, et al., 2007; Iwamoto, et al., 2013;
2014; Webster, et al., 2019). PNU-282987 is known to be a selective agonist of the α7 nAChR
(Bodnar, et al., 2005; Hajós, et al., 2005; Mata, et al., 2015). Many neurons within the retina
contain α7 nAChRs, including bipolar cells, some amacrine cells and retinal ganglion cells.
Under physiological conditions, ACh released from starburst amacrine cells does not initiate
regeneration. However, when PNU-282987 is applied as eye drops, it can stimulate non
neuronal α7 nAChRs on RPE that are separated from the neural retina. RPE cells contain α7
nAChRs, are known to secret at least 20 different compounds under normal physiological
conditions including growth factors and hormones, have been shown to be involved in
development of the mammalian retina, and are separated from acetylcholine stimulation under
normal physiological conditions by the outer limiting membrane (Grierson, et al., 1994; Yoshii,
et al., 2007; Mahabadi, et al., 2019). Results from this lab have led to the hypothesis that
stimulation of α7 nAChRs on RPE with PNU-282987 containing eye drops, causes the release of
signaling molecules from RPE to trigger dedifferentiation of Muller glia (Webster, et al., 2019).
Evidence to support this hypothesis has been obtained from experiments where RPE-J cell lines
were treated with 100nM PNU-282987 in DMSO. After a thorough rinsing to remove any
residual PNU-282987, the supernatant obtained from cultured RPE cells treated with
PNU282987 was sufficient to trigger cell cycle reentry of Müller glia (Webster, et al., 2019).
The work presented in this thesis was designed to explore the involvement of known
regenerative pathways that occur in other vertebrates where dedifferentiation of Müller glia
4

cells occurs. Based on preliminary results obtained from this lab and from the previous
research described, it was hypothesized that the HB-EGF/Ascl1/Lin28a pathway described in
regeneration of the zebrafish retina is activated in Müller glia after stimulation with the α7
nAChR agonist, PNU-282987. The experiments described here were performed to determine
what genes and pathways are activated in Müller glia following exposure to PNU-282987
treated RPE cells. The results from this pathway analysis were compared to published pathways
involved in development of the mammalian retina as well as to mechanisms by which zebrafish
and other non-mammalian vertebrates are able to dedifferentiate the retina in response to
injury, such as the HB-EGF/Ascl1/Lin28a pathway. Additional experiments were performed in
order to verify de-differentiating of adult Müller glia to produce retinal progenitor cells and to
determine if communication between RPE and Müller glia is sufficient to produce retinal
progenitor cells in vivo.
The following sections provide background information in neurogenesis, retinal
anatomy/physiology, retinal development, RPE, Müller glia and the previous research from this
lab that has led to these studies. The conclusion of this general introduction ends with
revisiting the main hypothesis of this study as well as listing the specific aims that were
addressed.

1.2 Neurogenesis
Tissue regeneration provides a source for restoration of function after damage due to
injury or disease (Wan, et al., 2016). The inhibition of neuronal proliferation in adulthood,
including the neuronal retina, is prevalent in all mammals, but not in all nonmammalian
vertebrates (Lamba, et al., 2006; Wan, et al., 2012; Centanin, et al., 2014; Gorsuch, et al., 2014).
5

A great deal of current research has been designed to understand the mechanism by which
some nonmammalian vertebrates, including urodele amphibians, post-hatch chicken, teleost
fish are able to regenerate the retina as adults in response to injury (Vihtelic, et al., 2000;
Fischer, et al., 2001; Rio‐Tsonis, et al., 2003).
Urodele amphibians, such as the salamander newt, are capable of regenerating
complete retina and lens in adulthood (Rio‐Tsonis, et al., 2003; Yoshii, et al., 2007). The entire
neuronal retina can be removed and regenerated (Araki, 2014), which occurs through
transdifferentiation of RPE cells (Fischer, et al., 2001; Rio‐Tsonis, et al., 2003). In newt,
following removal of the neuronal retina, RPE cells lose their characteristic differentiated
phenotype and dedifferentiate into retinal progenitor cells, which then undergo complete
histogenesis of the neural retina (Araki, 2014). While the ability to regenerate the retina is not
conserved in other vertebrates, the ability to regenerate the entire neuronal retina from RPE
alone becomes lost or inhibited in evolutionary time (Araki, 2014).
In chick, Müller glia that typically provide neuronal support cells of the retina have been
shown to be the source of regenerated neurons in the retina (Fischer, et al., 2001). Following
neurotoxic injury to the chick retina, Müller glia divide and produce retinal progenitors which
then differentiate to retinal neurons (Fischer, et al., 2001). During dedifferentiation, Müller glia
express progenitor genes such as Ascl1 and Notch (Hayes, et al., 2007). This effect in chick is
limited to early periods of postnatal development (Araki, 2014) and the amount and type of
neurons produced in chick is limited to fewer and less variation in neuron type than compared
to teleost fish (Fischer, et al., 2001).
In teleost fish, such as the zebrafish, the Müller glia respond to injury of any retina cell
type by de-differentiating and re-entering the cell cycle (Vihtelic, et al., 2000; Wan, et al., 2016).
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Cell cycle re-entry leads to proliferation of large numbers of retinal progenitor cells (Meyers, et
al., 2012). Retinal progenitor cells are multipotent precursor cells which are able to differentiate
into and replace lost adult neurons (Semo, et al., 2016). Follow dedifferentiation in zebrafish,
Müller glia-derived progenitor cells (MGPC) are able to differentiate into all retinal neuron
types, including Müller glia themselves (Wan, et al., 2012; 2016; Tappeiner, et al., 2016).
Multiple signaling pathways are known to regulate Müller cell reprogramming in
zebrafish which leads to retina regeneration. Regeneration in zebrafish is initiated by injury
within the retina, which signal Müller glia to dedifferentiate via secreted factors (Wan, et al.,
2016). One of these factors, HB-EGF, is found at the injury site in the zebrafish retina and
stimulates activation of Lin28a and Ascl1, which play a major role in the dedifferentiation of
Müller glia to MDPCs (Nelson, et al., 2009; Wan, et al., 2012; 2016). HB-EGF works upstream of
the Wnt/β-catenin signaling cascade, which is required for maintaining retinal progenitor fate
following dedifferentiation and control progenitor proliferation (Wan, et al., 2016) (Meyers, et
al., 2012). Inhibition of Notch signaling through enhanced MAPK signaling is found to increase
Müller glia proliferation in the zebrafish retina as well (Meyers, et al., 2012; Wan, et al., 2016).
Components of the sonic hedgehog (Shh) pathway are also involved in reprogramming cells
(Hochedlinger, et al., 2009; VandenHurk, et al., 2016). For example, Shh component Mmp9
regulates essential regeneration genes in zebrafish like Lin28a (Kaur, et al., 2018).
However, Müller glia do not proliferate under normal physiological conditions in adult
zebrafish, or in other adult vertebrates (Liu, et al., 2019). While positive factors stimulate the
proliferative potential of Müller glia in zebrafish following injury, some endogenous factors
appear to inhibit Müller glia proliferation in the absence of injury. MicroRNA let-7 has been
found to be involved with differentiation of Müller glia and is part of a Lin28/let-7 signaling loop
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which regulates the decision to adopt stem cell fate or differentiate fully in zebrafish
(Ramachandran, et al., 2010; Kaur, et al., 2018). Let-7 is also found to be involved with Shh
signaling (Kaur, et al., 2018). However, mammals have very little regenerative capacity in
adulthood for neuronal tissues (Ramachandran, et al., 2010; Wan, et al., 2016). In mammals,
neurogenesis is typically only found to be active during prenatal development (Czajam, et al.,
2012).
Instead, injury in the adult mammalian retina typically generates the formation of scar
tissue and loss of function known as reactive gliosis (Aguayo, et al., 1991; Hippert, et al., 2016;
Graca, et al., 2018). It is understood that for many adult mammalian neuronal cell types, the
ability to dedifferentiate in response to injury in adulthood is not completely lost, but rather
becomes inhibited due to a change in plasticity of adult neurons (Karl, et al., 2010; Tappeiner, et
al., 2016). It is thought that this ability may be accessed under appropriate conditions
(Merrell, et al., 2016), which is addressed in this thesis study.
The pathways by which zebrafish are able to regenerate the retina in response to injury,
have been used as a template in this study to analyze changes in gene expression following
exposure of Müller glia to PNU-282987 treated RPE supernatant, which activates
dedifferentiation in Müller glia (Webster, et al., 2019). Zebrafish pathways have been looked at
closely given the similarities in the characteristics of dedifferentiation found in previous work
from this lab, where Müller glia are becoming mitotically active during adulthood to generate
retinal progenitor cells (Webster, et al., 2019).
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1.3 Retinal Anatomy and Physiology
1.3.1 Retinal Anatomy
The mammalian retina lies in the back of the eye (Kolb, 2011). The neural retina consists of 6 cell
types; photoreceptors, bipolar cells, ganglion cells, horizontal cells, amacrine cells and Müller glial cells.
The cell bodies of the first 5 neuronal types mentioned are stacked in 5 alternating layers, with cell
bodies located in the inner nuclear, outer nuclear, and ganglion cell layers and synaptic connections in
the inner and outer plexiform layers (Figure 1) (Kolb, 2011). Phototransduction occurs in the
photoreceptors and the electrical signal is conveyed through the bipolar cells to ganglion cells, which
sends the information to the brain via the optic nerve. Along the retinal path, the electrical signal is
modulated by horizontal and amacrine cells in order to properly integrate information relayed to the
optic nerve (Kolb, 2011).

Figure 1. Anatomy of the mammalian retina.
The outer nuclear layer containing the
photoreceptors is the outermost layer of the
neuronal retina. Axons of the ganglion cells, in
the ganglion cell layer, form the optic nerve
leading to the brain.
Image created using Biorender.
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1.3.2 Retinal Circuitry
When light enters the eye through the lens, it travels past the layers of the retina before
photons of light are detected by pigments that lie in the outer segments of the photoreceptors
(figure 1). Photoreceptors detect photons of light and a trigger a change in photoreceptor cell
membrane potential, known as phototransduction (Kolb, 2003). The two types of
photoreceptors are rods and cones. Rods are extremely sensitive to light and can detect a single
photon of light. They are responsible for dim light vision. Cones require a larger number of
photons to produce a signal and are responsible for vision in bright light and color discrepancy
(Molday, et al., 2015).
Rods and cones synapse onto their respective bipolar cells. No bipolar cells have been
identified in mammals which synapse onto both rods and cones (Carlson, 2017). There are
approximately 10 types of cone bipolar cells and only one known type of rod bipolar cell
(Nicholls, et al., 2001). Their function is to transmit electrical signal to retinal ganglion cells,
which then carry the signal to the brain for image processing (Carlson, 2017). The axons of
retinal ganglion cells leave the retina via the optic nerve. Fibers from each eye cross the optic
chiasm and terminate in the opposite side of the brain (Remington, 2012; Demb, et al., 2015).
The optic tract within the brain carries these fibers from the optic chiasm to where they
synapse in the lateral geniculate nucleus (LGN) (Demb, et al., 2015). The LGN is the relay center
within the thalamus for the visual pathway (Corbett, et al., 2018). The fibers then leave the LGN
and terminate in the visual cortex of the occipital lobe where final visual perception occurs.
Here, visual information is transferred to neurological centers and visual association areas
(Remington, 2012).
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1.3.3 Phototransduction
Phototransduction is the process by which light is converted into a change in electrical
potential across a cell membrane. Phototransduction occurs through G-protein mediated signal
transduction. Photons of light enter the eye and are projected to the back of the eye onto the
retina. Photoreceptors of the retina detect photons of light. In mammalian retinas,
photoreceptors are depolarized in the dark and hyperpolarize in response to light by the
process of phototransduction. The change of membrane potential is conveyed through the
retina to the brain.
Phototransduction occurs due to visual pigments found in the outer segments in rods an
cones. In the rods, the visual pigment is called rhodopsin, which consists of the protein opsin
and a Vitamin A derivative, retinal. At rest, retinal exists in a bent confirmation known as 11-cis
retinal. When photons of light hits rhodopsin, 11-cis retinal changes confirmation to all-trans
retinal (Tsin, et al., 2018). The isomeric change in retinal causes opsin to also change shape,
resulting in the G-protein transducin, to break away from rhodopsin. The alpha subunit of newly
freed transducin binds to cGMP phosphodiesterase (PDE), a molecule within the rod which,
when activated, converts cGMP to 5’GMP (Tsin, et al., 2018). This conversion causes a decrease
of cGMP within the cell and closes cGMP gated channels, which normally allow influx of sodium
and calcium when cGMP is present (Fu, 2018). As less sodium enters the cell, the photoreceptor
hyperpolarizes and glutamate release from the synaptic terminal is halted. In the absence of
light, photoreceptors are depolarized due to relatively high levels of cGMP, low levels of
activated PDE and influx of sodium and calcium through cGMP gated channels (Kolb,
2003; Fu, 2018).
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1.3.4 Modulation of the Inner Retina
Horizontal and amacrine cells act to modulate the information flowing from
photoreceptors to bipolar cells in the outer plexiform layer, and from bipolar cells to retinal
ganglion cells in the inner plexiform layer, respectively (Figure 1) (Chaya, et al., 2017).
Horizontal cells are bound together by gap junctions in the outer retina and receive
glutamatergic input from photoreceptors which is used to provide feedback to photoreceptors
and bipolar cells (Thoreson, et al., 2013). Horizontal cells modulate photoreceptor output using
hemichannel-mediated ephaptic feedback (Kamermans, et al., 2001; Fahrenfort, et al., 2004),
PH-mediated feedback (Barnes, et al., 1993; Hirasawa, et al., 2012) and through GABAmediated
lateral inhibition of neighboring cells (Wu, 1992; Tatsukawa, et al., 2005). Horizontal cells are
involved in the ability for our eyes to see well in under both bright and dim conditions
(Masland, 2012). Negative feedback from horizontal cells to bipolar cells induces lateral
interactions within the retina which allow for greater spatial discrimination (Thoreson, et al.,
2013).
Amacrine cells are the most diverse type of cell within the retina. Over 40 different
subtypes having been categorized based on morphology, neurotransmitters and function (Kolb,
2005). Amacrine cells synapse at the inner plexiform layer onto other amacrine cells, bipolar
and ganglion cells (Kolb, 2005; Chaya, et al., 2017). All amacrine cells serve to integrate and
modulate temporal information into a visual message to be transmitted to the ganglion cells
(Gollisch, et al., 2010; Masland, 2013; Chaya, et al., 2017). Amacrine cells were named because
they were thought to lack axons, and only be composed of dendrites and a cell body (Kolb,
2005). The majority of amacrine cells do lack axons, however some large field amacrine cells
have been identified which have long, axon like processes which stay within the retina (Karten,
12

et al., 1980). Most amacrine cells are inhibitory neurons that release GABA or glycine (Masland,
2013). However, one type of amacrine cell called the Starburst amacrine cell, named for its
striking star-like appearance, has been found to release acetylcholine as well as GABA to the
inner retina (Voigt, 1986) The ACh released from starburst amacrine cells is the only source of
ACh in the adult retina. In this thesis study, RPE cells are stimulated using an α7-nAChR agonist
(Webster, et al., 2017; Webster, et al., 2019). Under physiological conditions, acetylcholine
released from starburst amacrine cells is unable to affect RPE, due to separation of RPE from
most of the retina by the outer limiting membrane (Figure 1) (Masland, 1980).

1.3.5 α7 Nicotinic Acetylcholine Receptors
Nicotinic acetylcholine receptors (nAChRs) are characterized this way because they can
be activated by both acetylcholine and nicotine, making nicotine an agonist of the receptor.
There are 10 alpha subtypes of the receptor, named α1-10. Aside from avian subtype α8, all α
subtypes have been found in mammals (Pohanka, 2012). Each nAChR is formed by five radially
symmetric subunits with a pore in the center (Pohanka, 2012). Each subunit is comprised of
four transmembranous α helices, a large intracellular domain which is composed of one α helix,
and an extracellular component with affinity for acetylcholine and its agonists (Unwin, 2005;
Pohanka, 2012). In α7 nAChRs, as well as some other α subtypes, acetylcholine binds to the
receptor in a cavity formed by a disulfide bridge from two cysteine residues (Unwin, 2005;
Pohanka, 2012). The α7 nAChR is categorized as homopentameric because of its five identical
α7 subunits, unlike other receptors which have combinations of different subunits to alter
stereochemistry. The α7 nAChR is one of few nAChRs which can bind choline as well as
acetylcholine. Many nAChRs form ion channels for the selective flow of Na + and K+, however the
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α7 nAChR forms a channel for the selective flow of Ca 2+ (Corringer, et al., 1999; Pohanka, 2012).
Αlpha7 nAChRs are found in many places in the nervous system, including the brain, eye, spleen
and lymph nodes (Dmitrieva et al., 2007; Ritter et al., 2019). Within the retina, α7 nAChRs are
found in bipolar cells, some amacrine cells and retinal ganglion cells, as well as retinal pigment
epithelial cells located directly outside the neuronal retina (Dmitrieva, et al., 2007; Maneu, et
al., 2010).
Many drugs have been developed to manipulate α7 nAChRs. Agonists developed for the
treatment of Alzheimer’s disease and the cognitive deficiencies associated with schizophrenia
include ABT-107, SEN12333 and TC-5619. All of these drugs are currently or were previously
undergoing testing for the treatment of these diseases, but none are commercially available
currently (Hauser, et al., 2009; Roncarati, et al., 2009; Malysz, et al., 2010). One commercially
available treatment used as an antipsychotic in paranoid disorders and schizophrenia is
clozapine (Pohanka, 2012). Clozapine is associated with brain alterations which can reduce
psychotic episodes and suicidal thoughts in patients with schizophrenia (Tregellas, et al., 2011).
Clozapine is associated with rapid blood pressure decreases and therefore is only used as a last
resort medication (Tregellas, et al., 2011). PNU-282897 is a selective α7 nAChR agonist
originally developed by Pharmacia & Upjohn as a therapeutic treatment for schizophrenia and
showed some ability to reduce negative symptoms in animal models (Pohanka, 2012; Marcus,
et al., 2016). However, PNU-282987 is not commercially available as a treatment for
schizophrenia due to its affinity to bind potassium channels in the heart when given
systemically, leading to cardiac arrest (Pohanka, 2012).
Antagonists which inhibit the effects of α7 nAChR binding include methyllycaconitine
and α-bungarotoxin. Methyllycaconitine, derived from Consolida flowers, has the highest
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affinity to α7 nAChRs (Taly, et al., 2009; Pohanka, 2012). α-bungarotoxin originates from the
venom of the Taiwanese krait snake Bungarus multicinctus (Chu, 2005 ). α-bungarotoxin binds
irreversibly to the α7 nAChR (Chu, 2005 ; Pohanka, 2012) but also able to bind the GABA β3
subunit (McCann, et al., 2006).
It has been demonstrated in this lab that stimulation of α7 nAChRs in the neural retina,
using intravitreal injections of the selective agonist PNU-282987, is neuroprotective against the
loss of RGCs that typically occurs in glaucoma (Iwamoto, et al., 2013; 2014) in adult rats and
mice. ACh released from starburst amacrine cells was found to have an endogenous
neuroprotective effect that was previously undiscovered (Cooley-Themm et al., 2017).
However, when PNU-282987 is given as eye drops, it is absorbed through the back sclera of the
eye to reach α7 nAChRs on RPE to trigger a neurogenic effect in Muller glia. The mechanism of
the Muller glia’s response is being analyzed in this study.
1.3.6 Retinal Pigment Epithelium
The retinal pigment epithelium (RPE) is a specialized, pigmented monolayer of epithelial
cells directly outside the photoreceptor layer of the neuronal retina. Cells are attached at the
basal end to the choroid layer of the eye via the Bruch’s membrane (Simó, et al., 2010) (Figure
1). The major functions of RPE include the transport of nutrients and other molecules, the
absorption of light to prevent photooxidation, phagocytosis of photoreceptor membranes, and
secretion of various factors to the retina (Boulton, et al., 2001; Strauss, 2005; Simó, et al., 2010;
Sparrow, et al., 2014; Inana, et al., 2018). RPE are known to secrete at least 20 different
compounds, some of which are growth factors involved in early retinal development (Dutt, et
al., 2010).
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RPE cells form the outer portion of the blood retinal barrier, which regulates solute and
nutrient movement from the choroid and sub-retinal space (BRB) and is essential for
maintaining homeostasis in the outer retina (Bok, 1993; Marmorstein, 2001; Simó, et al., 2010).
RPE cells are connected by tight junctions which eliminates the possibility of free movement
between the neuronal retina and the choroid (Bok, 1993; Omri, et al., 2010) and serves as a
source of filtration and delivery system on what molecules may enter the retina. Specifically,
RPE take up nutrients such as glucose, retinol, ascorbic acid and fatty acids (Simó, et al., 2010)
from blood to deliver to photoreceptors (Bok, 1993). In addition, RPE cells are involved in
transporting ions and water from the sub-retinal space that build up in excess as a consequence
of the high metabolic turnover of the retinal neurons (Marmorstein, 2001).
The pigment in RPE form a dark monolayer behind the photoreceptors of the retina
(Curcio, et al., 2011). This pigmentation allows RPE to absorb excess photons of light, allowing
photoreceptors to receive a clearer signal (Zarbin, et al., 2010) and contain various types of
pigment designed to absorb different wavelengths of light. The direct and frequent exposure to
light makes the photooxidation of lipids common, which is normally toxic to retinal cells (Curcio,
et al., 2011). However, RPE also contain high levels of antioxidants which prevent
photooxidative damage (Kolomeyer, et al., 2014)
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Figure 2. Phagocytosis of
photoreceptor outer segments
(POS) occurs once per day following
shedding of POS. POS are
detected by receptors in
RPE, move into RPE cells and are
broken down by phagosomes.
Image created using Biorender.

Over time,
photoreceptors accumulate
damage to their outer
segments and visual
pigments bleach out with
repeated exposure to light.
In order to maintain
photoreceptor excitability,
photoreceptors shed and regenerate their outer segments regularly. Once per day, based on
circadian rhythm (Mazzoni, et al., 2014), RPE cells are able to elongate their apical surface to
surround photoreceptor outer segments which have been shed. The shed portions bind to
phagocytic receptors on RPE which allow RPE to absorb shed outer segment portions and sends
them to phagosomes to be phagocytized (Figure 2) (Nguyen-Legros, et al., 2000; Feng, et al.,
2002; Mazzoni, et al., 2014).
RPE are known to produce growth factors and cytokines both in vivo and in vitro,
including FGF, TGF-β, IGF-I, PDGF, VEGF and TNF-α (Boulton, et al., 2001). The function of these
growth factors within the retina has not been completely characterized (Boulton, et al., 2001).
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However, conditioned media created from RPE cells in vitro from our lab has been shown to
cause dedifferentiation of Müller glia in adult mice (Dutt, et al., 2010).
Adult mammalian RPE are known to express α7-nicotinic acetylcholine receptors
(α7nAChR) (Maneu, et al., 2010). These receptors are known to be involved with cell
development, cell migration and cell death during development (Maneu, et al., 2010). RPE do
not receive acetylcholine stimulation from starburst amacrine cells in the neural retina under
normal, physiological conditions due to their separation from retinal neuronal synapses by the
outer limiting membrane (Figure 1). The outer limiting membrane is composed of tight
junctions surrounding photoreceptors below the cell bodies and Müller glia. The outer limiting
membrane is considered to be an ocular barrier which separates chemicals released in the
neural retina from reaching RPE. Due to this membrane, the only cells with direct exposure to
RPE are the end feet of the Müller glia and the outer segments of photoreceptors.
Previous work in our lab has led to a hypothesis that the α7-nAChR agonist, PNU-282987
(PNU), binds to α7-nAChRs on RPE cells and stimulate the release of factors which act upon
Müller glia to produce dedifferentiated retinal progenitor cells (Webster, et al., 2019). An HPLC
MS/MS study was performed previously which showed that PNU-282987, when administered
via eye drop to rat eyes, was detected and quantified in RPE cells when the PNU-282987 was
first dissolved in the lipophilic vehicle, 0.5% Dimethylsulfoxide (DMSO) (Linn, et al., 2018).
Therefore, eyedrop application of PNU-282987 represents an artificial way to stimulate RPE
α7nAChRs in adult mice as RPE do not normally receive acetylcholine stimulation from starburst
amacrine cells due to the inner limiting membrane. There are a number of partial α7-nAChR
agonists commercially available. Past studies using these compounds have found that
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PNU282987 is the only commercially available α7-nAChR agonist that leads to induced
dedifferentiation of Müller glia in adult mice. Other α7-nAChR agonists do not produce the
same effect (Webster, et al., 2017), suggesting activation of the α7-nAChRs in RPE with
PNU282987 binds differently or triggers different effects than other similar agonists.

1.3.7 Müller glia
The Müller glia are the major neuronal support component of the retina. Their nuclei
are located in the inner nuclear layer and they are the only cell type to span the entire retina
(Figure 1). The major function of the Müller glia within the adult retina is to maintain structural
and functional stability for the neuronal cells in the retina (Goldman, 2015). Duties of the
Müller glia include the uptake of excessive neurotransmitters to regulate the cell environment,
debris removal, funneling of excess water out of the retina, regulation of potassium levels and
glycogen storage (Reichenbach, et al., 2013). Müller glia are also known to be critical to the
development of the retina in mice, where they promote retinal growth and histogenesis
(Bhattacharjee, et al., 1975). Within the retinal development of nonmammalian vertebrates,
Müller glia are known to serve as guideposts to developing axons in the chick retina (Meller, et
al., 1976), and play a role in synaptogenesis in zebrafish (Phillips, et al., 2011).
Müller glia are remarkably resilient to damage, which can be attributed to their ability to
respond to injury by changing their morphology, biochemistry and physiology (Fischer, et al.,
2001; Bringmann, et al., 2009; Gorsuch, et al., 2014). In mammals, this injury response is
reactive gliosis and leaves scar tissue and loss of function (Goldman, 2015). However, in other
nonmammalian vertebrates which are capable of adult regeneration, Müller glia are the source
of new proliferation within the retina in response to injury (Goldman, 2015). It is thought that
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this regenerative ability is conserved in mammals but inhibited and may be initiated with
activation of the right factors within the cells (Merrell, et al., 2016).

1.4 Mammalian retinal development
Though the retina is located peripherally, it is a portion of the central nervous system.
During development, the diencephalon, a division of the forebrain, forms an out-pocketing
called the optic vesicle. The optic vesicle undergoes invagination to form the optic cup. The
inner wall of the optic cup forms the retina while the other wall forms the retinal pigment
epithelium (Purves, et al., 2001). Transcriptional regulation is responsible for the distinction
between the neural retina and the retinal pigment epithelium in early development (Heavner,
et al., 2012). The eye develops specifically from the neuroepithelium, surface ectoderm, and
mesenchyme. The neuroepithelium forms the RPE layer, ciliary body, and iris. The surface
ectoderm forms the lens, cornea, and eyelid. Finally, the mesenchyme forms the sclera, stroma,
blood vessels, muscles, and the vitreous of the eye.

In this thesis, we demonstrate that the Müller glia generate retinal progenitor cells (RPC)
when stimulated with supernatant from PNU-282987 treated cultured RPE cells. RPCs are
stem-cell-like, multipotent precursor cells which are able to differentiate into any retinal cell
type. RPCs may divide symmetrically or asymmetrically. Symmetrical divisions result in more
RPCs whereas asymmetrical divisions result in both new RPCS and mitotically-inactive,
differentiated neurons (Lamba, et al., 2006; Semo, et al., 2016). The specific type of cell which
RPCs differentiate into is driven largely by temporally regulated cell signals. Previous studies
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from our lab have demonstrated that RPC generated from Müller glia in response to
PNU282987 eye drops is due to asymmetric division (Webster et al., 2019).

In mice, ganglion, horizontal and amacrine cells are the first retinal cell types to begin
development, followed closely by the cones, then rods. Horizontal and ganglion cells are the
only cell types to fully develop before birth. Approximately 3 days post-birth (P3), cones and
amacrine cells are the next to complete development, followed by Müller cells at P7, bipolar
cells at P9 and lastly rods at P12 (Figure 3) (Young, 1985; Livesey, et al., 2001; Zhang, et al.,
2011). Horizontal cells, ganglion cells, cones, and amacrine cells are considered early born cells,
while rods, bipolar cells, and Müller glia are considered late born cells (Heavner, et al., 2012).
All of these cells derive from a common pool of retinal progenitor cells (Marquardt, et al.,
2002). Full synaptic connectivity is achieved with the mouse 30-40 postnatal, making this the
time when the retina is considered fully developed (Gorfinkel, et al., 1988; Wachtmeister,
1998).
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Figure 3. Timeline of cell genesis is the mouse retina. Birth is Day (0), embryonic development
left of (0) and postnatal development right of (0). Time courses are approximated based on
work published by Young, 1985 (Young, 1985). Image created using Biorender.
Following is the basic lineage by which retinal cells are produced from retinal progenitor
cells in mice. This pathway is highly conserved among vertebrates. In the developing retina,
multipotent retinal progenitors are NOTCH1 and PAX6 positive. Then, one of these two factors
will be lost. Cells which lose PAX6 and remain NOTCH1 positive will become bipolar cell,
photoreceptor or Müller glia progenitors (Shaham, et al., 2012). Cells which lose NOTCH1 and
remain PAX6 positive will become retinal ganglion, horizontal, photoreceptor or amacrine
progenitor cells. If any of these RPCs lose their NOTCH1/PAX6 marker and express OTX2, they
may become rod or cone progenitors (Hitchcock, et al., 1996).
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Further down the lineage tree, if Notch1 is left on and no other factors come into play, a
differentiated Müller glia will form. If Notch1 is lost and Vsx2 is expressed, a bipolar cell will
form (Fuhrmann, et al., 2014). If Atoh7/Math5 (AKA Ascl1) is expressed down the Pax6 lineage,
a retinal ganglion cell will form (Wang, et al., 2001; Song, et al., 2015). If Pax6 remains and
Oct1/2 is expressed, horizontal and amacrine progenitors are produced. From Oct1/2,
expression of NeuroD1 will produce fully differentiated amacrine cells. Alternatively,
expression of TFAP A/B will produce horizontal cells from Oct1/2 expressing cells. Further
signaling is required to differentiate into subtypes, of which there are many. The
aforementioned markers were considered for a potential role in this study.
1.5 Background

Figure 4. Expression of BrdU positive cells in the adult
mouse retina. Panel A shows the retina of an adult mouse
given BrdU eyedrops alone for 7 days and panel B shows
the retina of an adult mouse given BrdU/PNU282987
eyedrops for 7 days. BrdU positive cells (green) are seen
in the inner nuclear layer, outer nuclear layer and the
ganglion cell layer. Retinal sections were counterstained
with DAPI (blue). Scale bar = 100 microns.

Previous research published from this lab has demonstrated that supernatant obtained
from RPE cells treated with PNU-282987 was sufficient to induce cell cycle reentry in adult
Müller glia when the supernatant was injected into the eyes of adult mice. Mitotic activity was
indicated by the presence of 5-bromo-2’-deoxyuridine (BrdU) positive cells (Webster, et al.,
23

2017). BrdU is a thymine analogue which incorporates into the genome of cells entering the S
phase of mitosis and indicates mitotic activity. It was first demonstrated that PNU-282987
(PNU) was found to produce BrdU positive cells in Müller glia when BrdU and PNU-282987 was
administered as eye drops to adult mice once a day for seven days (Figure 4). Animals were
sacrificed, retinas were removed, processed and counterstained with DAPI. Expression of BrdU
positive cells was seen in all three nuclear layers. Time and dose-dependent studies confirmed
migration of proliferating cells that were initiated from Müller glia in the inner nuclear layer
(Webster, et al., 2017; 2019).

Figure 5. Müller glia are the source of BrdU+ cells. Panel A is a confocal image obtained from a rat retina
treated with BrdU alone. Panel B and C were treated with BrdU and PNU-282987, and immunostained with
an antibody against BrdU (green) and counterstained with DAPI (blue). Panel C was labeled with an antibody
against Vimentin (red), showing proliferation of BrdU positive cells from Müller glia (Webster, et al., 2017). Scale
Bars represent 20 microns.

The source of BrdU positive cells was hypothesized to be from Müller glia, which is
similar to the cellular source of regeneration in zebrafish and other teleost fish (Gorsuch, et al.,
2014). In previous studies using adult Long Evans rats, one eye was treated with eye drops
containing 1 mg/mL BrdU for two weeks in PBS. The other eye from the same animal was
treated with both BrdU and 1 mM PNU-282987 for the same time period. The animals were
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sacrificed after one month and retinas were removed and stained for anti-BrdU and Vimentin, a
type III intermediate filament protein expressed in Müller glia. As seen in Figure 5, treatment
with PNU-282987/BrdU eyedrops initiated BrdU positive cells (Figure 5B) and co-labeled with
the Muller glia marker vimentin in Figure 5C. The effects of PNU-282987 were blocked if the
α7 nAChR antagonist, MLA, was applied as eye drops before PNU-282987/BrdU. These data
support the hypothesis that proliferation of adult rat retinal neurons is the results of Müller glia
derived progenitor cells after application of PNU-282987 (Webster, et al., 2017; 2019).
Müller glia do not contain α7 nACh receptors and therefore cannot be the direct target of an α7
nAChR agonist (Dmitrieva, et al., 2007; Iwamoto, et al., 2013; Webster, et al., 2019).
PNU282987 was developed by Pharmacia & Upjohn as a selective α7 nAChR agonist. There are
9 different functional types of nicotinic acetylcholine receptors in mammals, two of which
contain α7 receptor subunits; the α7 homopentameric receptor and the α7β2 receptor. In the
mammalian retina, only α7 homopentameric receptors are found. Of the seven cell types
located in the neuronal retina, bipolar, amacrine and retinal ganglion cells have α7 nACh
receptors. However, these cells cannot be the cause of proliferation in the Müller glia as
acetylcholine is continually released from starburst amacrine cells in the neural retina under
physiological conditions, stimulating these receptors but not producing the proliferation seen
with PNU-282987.

Once it was confirmed that PNU-282987 induced BrdU positive cells from Müller glia,
cell types outside of the neuronal retina were considered as the direct target of PNU-282987.
Retinal pigment epithelial cells were considered as a potential target for PNU-282987 for two
reasons. First, RPE cells in adult mammals contain α7 nACh receptors (Dmitrieva, et al., 2007;
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Maneu, et al., 2010). Secondly, they are directly outside of the neuronal retina but are not
stimulated by acetylcholine released in the retina due to separation by the outer limiting
membrane. This membrane contains tight junctions that limits communication between RPE
and the neuronal retina to specific channels.

To test the hypothesis that PNU-282987 acts upon RPE cells to communicate with
Müller glia to undergo dedifferentiation, RPE-J cells in culture were treated with 100 nM
PNU282987 for 24 hours and washed thoroughly to remove all traces of PNU. Controls were
left untreated or were treated with 1 uM MLA for 8 hours followed by 100 nM PNU-282987
for 24 hours. Cells were then allowed to incubate in normal culture media for various
timepoints (0-72 hours). After different timepoints, the supernatant from cultured RPE cells
under the different treatment paradigms was injected into the vitreal chamber of adult mice.
PBS eyedrops containing BrdU was given to mice for 2 weeks before the animals were
sacrificed and processed for evidence of any BrdU positive cells. In eyes injected with control
untreated media
(Figure 6B) no BrdU positive cells were found. However, robust BrdU incorporation (Figure 6C)
was seen in the ONL and INL following injection of RPE supernatant from cells treated with
PNU-282987. With MLA pretreatment (Figure 6D), few BrdU positive cells were visible. This
experiment supported the hypothesis that PNU-282987 acts on α7 nACh receptors in RPE cells,
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which then communicate with Müller glia to induce cell cycle reentry.

Figure 6. PNU-282987 treated RPE Supernatant leads to BrdU+ Cells.
Panel A is an illustration of
treatment schematics for the supernatant experiment. Panel B represents a confocal image obtained after
injection of control untreated media. Panel C was obtained after injection of PNU-282987 treated media from
cultured RPE cells. Panel D is an image obtained when RPE cells were pretreated with MLA before PNU-282987.
Panel E
provides quantification of BrdU labeling in retinas of the previous described conditions. Scale bar = 100 microns.

It was hypothesized that BrdU positive cells are induced after application of PNU282987
due to dedifferentiation of Müller glia into retinal progenitor cells (RPC). To determine if the
PNU-282987 induced BrdU positive cells are RPCs, three different RPC markers have been used
in this lab; PAX6, Nestin, and SOX9. Figure 7 shows an adult mouse retina treated with eye
drops containing 1 mM PNU-282987 and 1 mg/mL BrdU for 1 week. The retina
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was immunoassayed with antibodies against BrdU (green) and SOX9 (red). Cells were found in
the inner nuclear layer which were both BrdU and SOX9 positive (Figure 7A) (Webster, et al.,
2017). Figure 7B shows double labeling of PAX6 positive (blue) and BrdU positive (green) cells in
the outer nuclear layer of a retina treated with PNU-282987 in conditions similar to that
described for panel A (Webster, et al., 2019). Figure 7C shows the same conditions of treatment
with double labeling of Nestin positive and BrdU positive cells as well as vimentin labeling
(Webster, et al., 2019). The presence of these three markers in the same cells as BrdU positive
cells indicates that PNU-282987 is inducing dedifferentiation of Müller glia to RPCs in adult
mice.

Figure 7. Retinal progenitor markers in the adult mammalian retina. Panel A shows double labelling of SOX9
(red) and BrdU (green). The arrow indicates a BrdU+ cell, the star a SOX9+ cell and the arrowhead a cell that is
both BrdU+ and SOX9+. Panel B shows double labelling of All retinas were treated with PNU-282987 and double
labeled for BrdU and the respective RPC marker. Panel B shows double labeling of BrdU and Nestin as well as
Vimentin. The white arrow indicates a Nestin positive cell which was not indicated in the controls. A control
untreated retina was labeled under the same conditions for each marker, producing no BrdU positive
cells and showing no indication of RPC markers without PNU-282987 treatment. Panel C shows double labeling of
BrdU and PAX6. The white arrows show BrdU+ cells, the arrowhead shows a PAX6 positive cell and the
yellow arrows indicates a cell which is both Pax6+ and BrdU+. Scale bars represent 100 microns.
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1.6 Specific Aims

The adult mammalian neuronal retina is not known to proliferate after early
development (Webster, et al., 2019). As a result, neurodegenerative diseases of the retina such
as glaucoma, macular degeneration, retinal ischemia and diabetic retinopathy lead to
irreversible loss of retinal ganglion cells in adult mammals. Research indicates possible
neuroprotective or neurotrophic effects of alpha 7 nicotinic acetylcholine receptor (α7 nAChR)
agonists in prolonged activation of α7 nACh receptors (Mudo, et al., 2007). Our previous work
has indicated that administration of PNU-282987, an α7 nAChR agonist, induces cell cycle
reentry of Müller glial cells in the mammalian retina. However, Müller glial cells do not contain
α7 nAChR. Instead, evidence supports the hypothesis that PNU-282987 is acting upon retinal
pigment epithelial (RPE) cells directly outside the neuronal retina, activating an unknown
signaling pathway which induces cell cycle reentry in Müller glial cells. Multiple signaling
pathways are known to regulate Müller cell reprogramming in zebrafish which leads to retina
regeneration, including Wnt/β-catenin, HB-EGF/Ascl1, and Sonic Hedgehog (Shh) Signaling
(Meyers, et al., 2012; Wan, et al., 2012; Kaur, et al., 2018). This proposal seeks to define the
mechanism by which Müller glia are producing retinal progenitor cells through dedifferentiation
after exposure to supernatant of RPE cells treated with PNU. The pathways by which zebrafish
are able to regenerate the retina in response to injury have been used as a template in this
study to analyze changes in gene expression following exposure of Müller glia to PNU-282987
treated RPE supernatant.
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Hypothesis: Stimulation of the α7 nAChR in adult mice retinal pigment epithelium induces the
HB-EGF/Ascl1/Lin28a pathway in Müller glia to drive cellular dedifferentiation to retinal
progenitor cells.

Specific Aim #1: Determine intracellular signaling pathways elicited in Müller glial cells after
contact with supernatant obtained from RPE cells treated with PNU-282987.

Rationale: Our previously published work demonstrated that supernatant obtained from
immortalized RPE cells following application and then removal of PNU-282987, was sufficient to
produce new, BrdU positive retinal ganglion cells (RGC) which originate from Müller glia if the
supernatant was injected into the eyes of adult mice and rats (Webster, et al., 2019). More
research is required to understand the mechanism by which PNU-282987 activation of RPE cells
leads to communication with Müller glia to induce adult neurogenesis. Experiments: RPE
cultures were treated with 100 nM PNU-282987 for 24 hours. RPE cultures were then
thoroughly washed to remove any residual PNU-282987 and Müller glia were exposed to
treated RPE cells via transwells for 8, 12, 24 and 48 hours. DMSO was used as a vehicle control
and DMSO treated RPE was exposed to Müller glia for 48 hours. After treatments, Müller glia
cells were collected, and total RNA was extracted following previously described methodology
(Webster, et al., 2019). RNA samples were shipped overnight on dry ice to GeneWiz® for library
preparation, sequencing and bioinformatics. RNA sequencing results were verified using
qRTPCR analysis of extracted RNA collected under the same conditions. Results were then
compared with literature describing the mechanism by which some vertebrates, such as teleost
fish, are able to dedifferentiate the retina in adulthood in response to injury. These
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comparisons were used to determine a pathway by which dedifferentiation may occur within
the mammalian retina in response to PNU-282987.

Specific Aim #2: Determine if stimulation of Müller glia with PNU-282987-treated RPE
supernatant can lead to retinal progenitor cell marker.

Rationale: While the results from specific aim 1 have determined genes involved in Müller glia
dedifferentiation resulting from PNU-282987 treated RPE cells, the experiments outlined in
specific aim 2 have determined that RPC markers can be detected. In the designed experiments,
RPE cells in culture were treated for 24 hours with PNU. PNU-282987 was then thoroughly
washed away and RPE were allowed to grow in 8% FBS DMEM (Normal Media) for 72 hours.
Supernatant from RPE after 72 hours was transferred to Müller glia in culture for 48 hours.
Müller glia were then be counterstained with Hoescht stain to label nuclei and immunostained
for retinal progenitor cell markers using antibodies against Nestin, OTX2 and VSX210 (Lamba, et
al., 2006). Cells were viewed using confocal microscopy to identify markers of retinal progenitor
cells.

Impact: This proposal seeks to further our understand of the mechanism by which PNU-282987
induces dedifferentiation of the adult mammalian retina. Doing so has enhanced our
understanding of the limitations which exist in the mammalian retina that inhibit its ability to
proliferate in adulthood.
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CHAPTER II

ROLE OF HB-EGF/ASCL1/LIN28A PATHWAY IN DEDIFFERENTIATION OF ADULT MAMMALIAN
MÜLLER GLIA
Megan L. Stanchfield, Sarah E. Webster, Mark K. Webster, Cindy L. Linn. Western Michigan
University, Department of Biological Sciences, Kalamazoo, MI 49008, USA.
Abstract
Previous studies from this lab have determined that dedifferentiation of Müller glia occurs
after eye drop application of an α7 nicotinic acetylcholine receptor agonist, PNU282987, to the
adult rodent eye. PNU-282987 acts on α7 nAChRs on retinal pigment epithelial cells to
stimulate production of Müller glia-derived retinal progenitor cells and ultimately lead to
neurogenesis. This current study was designed to test the hypothesis that the activation of the
HB-EGF/Ascl1/Lin28a signaling pathway in Müller glia leads to the genesis of Muller-derived
RPCs. RNAseq was performed on Müller glial cell lines (rMC-1) following contact with
supernatant collected from retinal pigment epithelial (RPE-J) cell lines treated with PNU282987.
Up- or down-regulated genes were compared with published literature of Müller glia
dedifferentiation that occurs in lower vertebrate regeneration or during early mammalian
development. HB-EGF was significantly up-regulated by 8 hours and expression increased
through 12 hours. By 48 hours, up-regulation of Ascl1 and Lin28a was observed, two genes
known to be rapidly induced in de-differentiating zebrafish Müller glia. Up-regulation of other
genes known to be involved in mammalian development and zebrafish regeneration were also
observed, as well as down-regulation of some factors necessary for Müller glia cell identity.
RNA-seq results were verified using qRT-PCR. Using immunocytochemistry, the presence of
genes associated with RPC identity, Otx2, Nestin, and Vsx2, were found to be expressed in the
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48 hour treatment group cultures. The results from this study will further our understand of the
mechanism by which Müller glia are dedifferentiating in response to PNU-282987 treated RPE
supernatant.
2.1 Introduction
Neurodegenerative diseases of the retina such as glaucoma, macular degeneration,
retinal ischemia and diabetic retinopathy lead to irreversible loss of retinal cells in adult
mammals (Velez-Montoya, et al., 2013; Weinreb, et al., 2014; Duh, et al., 2017; Dattilo, et al.,
2018). However, within the mammalian neuronal retina, neurogenesis does not typically occur
after early development (Dhomen, et al., 2006; Lamba, et al., 2006; Belecky-Adams, et al.,
2008). Decades of research has been performed in an effort to understand the inability of
mammals to regenerate the central nervous system in adults, given the fact that many other
animals are able to do so throughout adulthood (Dmitrieva, et al., 2007; Gorsuch, et al., 2014).
It is thought that the mechanism by which central nervous system regeneration occurs exists
within mammals but has been inhibited through evolutionary time (Chen, et al., 1998; Nicholls,
et al., 1999; Tanaka, et al., 2009; Echeverri, 2020).
Previous work from this lab has indicated that administration of PNU-282987, an α7
nAChR-specific agonist (Bodnar, et al., 2005; Iwamoto, et al., 2013; 2014; Mata, et al., 2015) via
eye drops onto adult mice and rat eyes induces cell cycle reentry of Müller glial cells leading to
genesis of new mature retinal neurons, that appeared first in the inner nuclear layer and then
migrated to the others (Webster, et al., 2017; Webster, et al., 2019). This observed inner
nuclear migration is consistent with regenerative capacities in developing mice (Tackenberg, et
al., 2009; Lahne, et al., 2016; Webster, et al., 2017). Cell cycle re-entry was indicated by the
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presence of 5-bromo-2’-deoxyuridine (BrdU) positive cells observed after eye drop application
of PNU-282987. The source of new BrdU positive cells was found to be Müller glia through
lineage tracing with a transgenic TdTomato-Muller glia reporter line(Webster, et al., 2017;
2019).
However, Müller glia do not express α7 nAChRs (Dmitrieva, et al., 2007; Iwamoto, et al.,
2013; Iwamoto, et al., 2014; Webster, et al., 2019). Of the cell types within the neural retina
which contain α7 nAChRs, namely bipolar, some amacrine cells and retinal ganglion cells
(Webster, et al., 2017; Hall, et al., 2019), ACh released from the starburst amacrine cells does
not induce proliferation or interkinetic nuclear migration of Müller glia under physiological
conditions. Instead, evidence was provided that PNU-282987 acts on the retinal pigment
epithelium (RPE) when applied as eye drops (Webster et al., 2019). RPE cells contain α7 nACh
receptors, are known to secret at least 20 different compounds under normal physiological
conditions including growth factors and hormones, and are separated from ACh stimulation
under normal physiological conditions by the outer limiting membrane (Grierson, et al., 1994;
Yoshii, et al., 2007; Maneu, et al., 2010). When PNU-282987 is administered as eyedrops into
the eyes of adult mice and rats, it is hypothesized that PNU-282987 binds to alpha7 nAChRs on
RPE directly outside the neural retina (Webster, et al., 2019) to release signaling molecules onto
the end feet of Müller glia to release signaling molecules onto the end feet of Müller glia that
asymmetrically divide to produce Müller-derived progenitor cells. Evidence to support this
hypothesis was provided by experiments in which RPE-J cell lines in culture were treated with
100nM PNU-282987 and the resulting supernatant was sufficient to produce cell cycle reentry
of Müller glia in adult rodents (Webster, et al., 2019).
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This mechanism of generating new neurons from Müller glia is consistent with
regeneration of the retina in adult zebrafish following injury. In zebrafish, the HBEGF/Ascl1/Lin28a pathway is found to be crucial in retinal regeneration following injury (Wan,
et al., 2012; 2016; Tang, et al., 2019; Silva, et al., 2020). HB-EGF is one of many ligands which
activate EGF receptors, others of which include EGF and TGFα (Wan, et al., 2012). HB-EGF is
found at the injury site of the injured zebrafish retina. It has been demonstrated that HB-EGF
activates regeneration-associated gene Ascl1, which has been shown to modulate histone
binding involved in dedifferentiation of neuronal cells(Vierbuchen, et al., 2010). Ascl1 activates
RNA binding protein Lin28a, a which is known to inhibit microRNA Let-7 (Yao, et al., 2016). Let-7
is involved in inhibition of proliferative abilities in adult Müller glia in zebrafish (Yao, et al.,
2016). When Let-7 is inhibited, the Wnt pathway is active, leading to dedifferentiation of Müller
glia to produce retinal progenitor cells (Yao, et al., 2016). In this current study, evidence will be
presented that these pathways are also involved in the PNU-282987 response in adult rodent
models.
This study is designed to explore regenerative pathways involved in dedifferentiation of
adult mammalian Müller glia cells to Müller-derived progenitor cells (MDPCs). These studies
will demonstrate that exposure of cultured Müller glia cells to supernatant from RPE cells
treated with PNU-282987 will induce genesis of MDPCs. In addition, the results from this study
support the hypothesis that the HB-EGF/Ascl1/Lin28a pathway is activated in Müller glia after
stimulation of α7 nAChR agonist, PNU-282987 in RPE adult rat cell lines contributing to cell cycle
reentry. The results from gene and protein analysis have been used to propose a gene
expression pathway involved in dedifferentiation of adult Müller glia. The results from pathway
analysis were compared to published pathways involved in development of the mammalian
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retina as well as to mechanisms by which zebrafish and other non-mammalian vertebrates are
able to regenerate the retina in response to injury. Additionally, it was demonstrated that
communication between activated RPE and Muller glia can induce progenitor-like fate in Muller
glia culture. Understanding these mechanisms is an important step in learning to control adult
neurogenesis and regeneration in the CNS.

2.2 Materials and Methods
2.2.1 Culture of RPE Cell Lines
RPE cells derived from rats (RPE-J; 4-6 passages) were grown in Dulbecco’s modified
Eagle’s

medium

containing

8%

fetal

bovine

serum,

1%

L-Glutamine,

and

1%

penicillinstreptomycin, using standard cell culture techniques and incubated in 33°C with 5% CO 2.
Immortalization of RPE cell lines requires incubation lower than the standard 37°C. Cell culture
reagents were obtained from ThermoFisher Scientific (Waltham, MA, USA). RPE-J cell cultures
were treated with dimethylsulfoxide (DMSO) (vehicle control) or PNU-282987 (100 nM;
SigmaAldrich, St. Louis, MO, USA) for 24 hours. Cells were plated in a T75 flask, 35mm dish for
immunocytochemistry or briefly in a 100mm transwell dish (Corning Inc., Corning, NY, USA) for
co-culture with a cell line of retinal Müller glia (rMC-1) and grown to 80% confluency. PNU282987
or DMSO was applied to transwell or 35 mm dishes for 1 hour. After thorough washing cells to
remove

any

residual PNU-282987, cells

were

processed for

RNA

extraction or

immunocytochemistry. 100 nM PNU-282987 was used in this study, as previous dose-response
studies from this lab have found 100 nM PNU-282987 to be the most effective dose (Webster
et.al., 2017).
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2.2.2 Culture of Müller glia Cell Lines
Retinal Müller glia cells derived from rats (rMC-1; 4-6 passages) were grown in Dulbecco’s
modified Eagle’s medium containing 8% fetal bovine serum, 1% L-Glutamine, and 1%
penicillinstreptomycin, using standard cell culture techniques and incubated at 37°C with 5% CO2.
After 3 days, cells were switched to 33°C with 5% CO2 so they could be co-cultured with RPE cells.
The change in temperature had no effect on Müller glia growth and morphology if they were first
cultured in 37°C with 5% CO2. Müller glia were co-cultured with RPE-J in transwells at 33°C with
5% CO2. Cell culture reagents were obtained from ThermoFisher Scientific (Waltham, MA, USA).
rMC-1 cell cultures remained untreated and were co-cultured with RPE-J cells that had previously
been treated with DMSO (vehicle control) or PNU-282987 (100 nM; Sigma-Aldrich, St. Louis, MO,
USA). rMC-1 cells were plated in a T75 flask, 35mm dish for immunocytochemistry, or briefly in a
100mm transwell dish (Corning Inc., Corning, NY, USA) and grown to 80% confluency for coculture
with RPE-J. For RNA extraction, Müller glia were exposed to treated RPE via transwells for set
times (8, 12, 24 or 48 hours). When these co-culture exposure times were completed, cells were
collected using 1:250 trypsin-EDTA and gently pelleted using centrifugation. For
immunocytochemistry, Müller glia were grown to 30% confluency and treated with RPE-J
supernatant after treatment with DMSO or PNU-282987 for 0, 8, or 24 hours.
2.2.3 RNA Extraction and RNAseq Analysis
Direct-zol RNA Miniprep kit (R2051; Zymo Research) was used for RNA extraction following the
protocol provided. RNA from Müller glia cells in culture was collected in RNase-free water and
stored at -80°C or on dry ice for overnight shipment to GeneWiz®. GeneWiz® performed
RNAseq Next Generation Sequencing (NGS) using the Illumina NextSeq 550 high-output
platform (Illumina, San Diego, CA). Sequence reads were trimmed using Trimmomatic v.0.36.
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Trimmed sequence reads were mapped to the Rattus Norvegicus Rnor6.0 reference genome
available on ENSEMBL. Unique gene hit counts were calculated using featureCounts (subread
package v.1.5.2). GeneWiz provided Deseq2 bioinformatics analysis. Pathway analysis was
additionally performed in this lab using Reactome (Fabregat, et al., 2014)..
2.2.4 Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) qRT-PCR
was preformed using the SuperScript III Platinum One-Step kit with ROX (11745500,
ThermoFisher) with RNA collected from each of the five timepoints, as described previously.
50ng of RNA was used for each reaction with a RIN ≥6 and set up in 10µL reaction volumes, as
per the manufacturers protocol. IDT and Thermo pre-designed primer/probe assays were used
(table 1) and efficiencies were validated for each primer/probe set to be between 90-110%
(supplemental table 1). Each sample was run in triplicate and each assay was repeated in
triplicate. For relative comparison of gene expression, the real-time results were analyzed using
the comparative Ct method (2-ΔΔCt) normalized to a Gapdh housekeeping control.
Table 1. Summary of primer probes used for qRT-PCR Taqman Assay.

Table 1. Primer/Probe Assays Used
Gene Symbol
HB-EGF
Ascl1
Lin28a
Fgf11
Fgf9
Sox9
Fzd9
Mmp9
Gli3
Bcat1
Bmp4
Gapdh

Gene Assay ID
Rn.PT.58.9646801
Rn.PT.58.17863661.g
Rn.PT.58.33962866
Rn.PT.58.5164978
Rn.PT.58.10285426
Rn.PT.58.29440750
Rn00596271_s1
Rn00579162_m1
Rn01538495_m1
Rn.PT.58.44552624
Rn.PT.58.36829962
Rn.PT.39a.11180736.g
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2.2.5 Immunofluorescence for Müller glia in Culture

Müller glia cells were grown to 30% confluency on 35mm dishes (ThermoFisher Scientific,
Waltham, MA, USA) and treated for 0, 8 and 48 hours with supernatant from RPE-J cells
previously treated with DMSO or with 100 nM PNU-282987 (Sigma-Aldrich, St. Louis, MO, USA)
for 24 hour. After thorough rinsing to remove any trace of PNU-282987, the cells were then
allowed to incubate for 24 hours in normal media. After treatment, Müller glia cells were fixed
using 4% paraformaldehyde (PFA) for 10 minutes at room temperature. PFA was then removed,
and cells were washed 3x with 2mL of 1X Phosphate Buffer Saline (PBS). To increase
permeabilization, 0.5% Triton X-100 in 1X Tris Buffer Saline (TBSTr) was then added and cells
were incubated at room temperature for 15 minutes. TBSTr was removed and replaced with
TBSTr with 10% Normal Goat Serum (NGS) for 4 hours to minimize non-specific binding. Primary
antibodies were diluted at a ratio of 1:300 in 1X TBS + 0.05% Triton X-100 with 1% NGS and
incubated overnight at 4°C. Primary antibodies (Table 2) were then removed and cells were
washed 3x with 1X TBS + 0.05% Triton X-100 for 10 minutes. Fluorescent dye labeled secondary
antibodies (Table 2) were added for 2 hours at room temperature in the dark, followed by
Hoescht counterstain (1:10,000) for 10 minutes at room temperature. Cells were again washed
3x with 1X TBS. Fluorescently labeled cells were viewed using Nikon C2+ scanning confocal
microscopy. Antibodies against OTX2, VSX2 (formerly CHX10) , and Nestin were used to identify
the presence of retinal progenitor cells, and Vimentin was used to label Müller glial
cytoskeleton as a positive control. All reagents were obtained from ThermoFisher Scientific
(Waltham, MA, USA) and antibodies were obtained from Abcam®, Inc. (Cambridge, MA, USA).
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In control studies, experiments were conducted to determine the specificity of all antibodies
used. Antibodies used in this study originated from rabbit, mouse, goat, donkey or sheep.
Antibody processing was performed on untreated Müller glia rMC-1 cells as well as in
experimentally treated cells of the same type to determine if positive labelling occurred in
untreated controls. Cells were processed with the primary antibody omitted. No significant
epifluorescence was observed if the primary antibody was omitted.

Table 2. Summary of primary and secondary antibodies used to test the presence of retinal progenitor cell markers
in Müller glia which were exposed to supernatant of RPE cells treated with DMSO vs PNU-282987.

Table 2.

Antibodies used in immunocytochemistry of rat-derived cell lines

1° Antibody

Immunogen

Mouse αVimentin
Mouse
αNestin

Müller glia
cytoskeleton

Cat.
Number
ab8978

1° Dilution

2°
Antibody
Goat
αmouse

Cat.
Number
ab150120

2° Dilution

Retinal
progenitor

ab6142

1:300

Goat
αmouse

ab150120

1:300

Rabbit
αOTX1/2

Retinal
progenitor

ab92515

1:300

Goat
αrabbit

ab150088

1:300

Sheep
αCHX10
(VSX2)

Retinal
progenitor

ab16141

1:300

Donkey
αsheep

ab150177

1:300

1:300

1:300

2.2.6 Statistical Analysis
Single comparisons involved a Student’s paired T-test for all culture experiments. For
experiments requiring multiple comparisons, one-way ANOVA with post hoc analysis using the
Holm-Bonferroni correction was performed. A Wald test was performed to generated p-values
and log2 fold changes of RNA Sequencing results. Results were considered significant if P ≤ 0.05
and log2 fold changes were >1 or <-1. Statistical analysis for RNAseq was provided by GeneWiz.
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Heat map samples of significant genes were determined by systematic sampling using the
equiprobability method to in order to accurately represent total sDEGs at each timepoint.

2.2.7 Bioinformatics
Bioinformatics performed by GeneWiz® provided significant differentially expressed
genes (sDEGs) and Volcano plots using the Wald test to determine DEGs with a P-value ≤ 0.05
and log2 fold changes >1 or <-1. Heat maps were generated using Morpheus and Violin Plots
using Plotly. Reactome was used to determine biological processes associated with pathways of
identified genetic markers. Binary Alignment Sequences (BAMs) were generated by GeneWiz®
using STAR Aligner v.2.5.2b. All other tables and graphs were generated using Excel.

2.3 Results
2.3.1 Experimental Design
Previous studies from this lab found that supernatant collected from (RPE) cells that were
treated with the α7-nicotinic acetylcholine receptor agonist, PNU-282987 (Sigma P6499), was
sufficient to produce cell cycle reentry of the adult mammalian Müller glia in the retina. These
same studies demonstrated that BrdU positive Müller glia dedifferentiate into retinal
progenitor cells (Webster, et al., 2017; Webster, et al., 2019). To identify changes in Müller glia
gene expression after exposure of RPE treated supernatant, mRNA sequencing was performed
(GeneWiz® Inc., New Jersey) from total RNA extracted from Müller glia. rMC-1 Müller glial cell
lines (Kerafast ENW001) were exposed to the supernatant collected from PNU-282987-treated
RPE-J cell lines (ATCC CRL-2240) via 75 mm Transwell (Corning 3419) dishes (Figure 15). RPE
cells were cultured for 8, 12, 24 and 48 hours in normal media (8% FBS DMEM with L-glutamine
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and Penicillin/Streptomyocin, Gibco 11971025) after exposure to 100 nM PNU-282987 for 24
hours, followed by thorough rinsing with PBS. Previously, RPE culture was treated with PNU for
24 hours, washed, and subsequently left in normal media for 72 hours before injection in the
mouse eye. This timeline induced robust BrdU incorporation (2019). Subsequent experiments
analyzed 12, 24, and 48h cultures which all showed some level of BrdU incorporation in the
mouse retina (unpublished). This information was used to select the appropriate time points in
order to see early changes in Müller glia transcripts as well as changes leading up to the
maximum response attainable while maintaining healthy cell cultures. In some 75mm transwell
dishes, RPE-J cells were treated with 1% DMSO for 24 hours instead of 100 nM PNU-282987 to
act as a vehicle control. Figure 8 summarizes the procedures used to perform these
experiments.

Figure 8. Schematic of methods performed to obtain RNA from Müller glia exposed to PNU-282987 treated RPE
cells. (A) 1: RPE-J treated for 24 hours with DMSO as a vehicle control. 2-5: RPE-J cells treated for 24 hours with
PNU-282987. PNU-282987 was removed and thoroughly washed away with PBS before being replaced with normal
media. (B) After PNU-282987 treatment and thorough rinsing, RPE were exposed to rMC-1 cells via transwells and
allowed to incubate for 8, 12, 24 and 48 hours. RNA was extracted from Müller glia and sent to GeneWiz® for RNA
sequencing. Some bioinformatics was performed by WHOM? to determine log2 fold changes of identified RNA
sequences compared to DMSO control. Results were compared to literature on factors involved in zebrafish retinal
regeneration and mouse retinal development.
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2.3.2 RNA Sequencing of Müller Glia Exposed to PNU-282987-Treated RPE Supernatant

In order to investigate transcriptional changes in Müller glia following the treatment
with PNU-282987 described in figure 8, RNA-seq analysis of Müller glial cell lines was
performed. Each of these samples was sequenced by GeneWiz® using the Illumina NextSeq 550
high-output platform (Illumina, San Diego, CA). Sequence reads were trimmed to remove
possible adapter sequences and nucleotides with poor quality using Trimmomatic v.0.36.
Trimmed sequence reads were mapped to the Rattus Norvegicus Rnor6.0 reference genome
available on ENSEMBL, as both cell lines are derived from rat. Unique gene hit counts were
calculated using featureCounts (subread package v.1.5.2), counting only unique reads which fell
on exon regions. Using DESeq2, a comparison of gene expression between the control and each
timepoint was performed to evaluate differentially expressed genes (DEGs). The Wald test was
used to generate p-values and log2 fold changes. Log2 fold changes were used to compare data
similarly to biologically detectable changes (Lovén, et al., 2012). Genes with a p-value <0.05 and
log2 fold change >1 or <-1 were considered significant differentially expressed genes (sDEGs).
Log2 fold expression changes were obtained in approximately 15,000 identified genes total for
the four timepoints. 1050 sDEGs were identified, and were compared with literature identifying
molecules of interest known to be involved in dedifferentiation of Müller glia in teleost fish
upon retinal injury (Ramachandran, et al., 2011; Wan, et al., 2012; Yao, et al., 2016; Meyers, et
al., 2012; Hitchcock, et al., 1996; Gorsuch, et al., 2014; Goldman, 2014; Fischer, et al., 2001;
Centanin, et al., 2014), as well as those involved in early development of the retina in
vertebrate mammals such as mouse and rat (Bhattacharjee, et al., 1975; Dhomen, et al., 2006;
Locker, et al., 2006; Nelson, et al., 2009; Phillips, et al., 2011; Wang, et al., 2001; Wright, et al.,
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2015; Xia, et al., 2016). Teleost fish, specifically zebrafish, were chosen as a comparative focal
point based on their ability to regenerate the retina in adulthood following injury and the
extensive availability of research published on this topic, in addition to the neurogenesis with
PNU resembling this regeneration. For ease of comparison, 100 molecules of interest per
timepoint were chosen as a focus for this study, illustrated in the heat map in Figure 9A. The
100 genes per timepoint chosen to represent the sDEG data were identified by systematic
sampling using the equiprobability method to accurately represent the distribution of log 2 fold
changes identified as significant at the timepoint.
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Figure 9. Expression changes over time (A) Heat map with of sDEGs from Müller glia RNA expression changes 8, 12,
24, and 48 hours post exposure to PNU-282987 treated RPE cells, compared to 48-hour DMSO control conditions.
sDEGs represented include a linear sample of total sDEGs per timepoint. Created using Morpheus. (B) Violin
distribution plots of sDEGs per timepoint at the timepoint represented.
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409 DEGs were found to be statistically significant (p-value <0.05, log2 fold change >1 or
<-1) at the 8-hour time point compared to DMSO control. 240 (58.7%) of which were
downregulated compared to control (log2 fold change between -1.81 and -8.01), while 169
(41.3%) were up-regulated (log2 fold change between 1.78 and 8.56). The majority (>50%) of
sDEGs down-regulated at 8 hours were found to be up-regulated by 24 and 48 hours post
treatment. Conversely, the majority (>50%) of sDEGs up-regulated at 8 hours were found to be
downregulated by 24 and 48 hours post treatment. Up- and down-regulation are relatively
consistent for 8 hour sDEGs. 420 DEGs were found to be statistically significant 12 hours post
treatment compared to the DMSO control. 237 (56.4%) of these were down-regulated
compared to the
DMSO control (log2 fold change between -1.70 and -7.64), while 183 (43.6%) were up-regulated
(log2 fold change between 1.69 and 8.17). Similar to the 8 hour post treatment condition, over
50% of genes up-regulated at 12 hours were down-regulated at 24 and 48, and vice versa. 272
statistically significant DEGs were identified 24 hours post treatment compared to the DMSO
control. 155 (57.0%) of the sDEGs at 24 hours were down-regulated (log2 fold change between
1.0 and -4.51) and 117 (43.0%) were up-regulated (log2 fold change between 1.0 and 6.78). The
majority (>50%) of sDEGs which were down-regulated at 24 hours were up-regulated or
unchanged/undetected at other timepoints. 339 statistically significant DEGS were found 48
hours post treatment compared to the DMSO control. 38 (11.2%) of these were downregulated
(log2 fold change between -1.01 and -1.54) and 301 (88.8%) were up-regulated (log2 fold
change between 1.0 and 8.71). 50% of sDEGs at the 48 hour timepoint had log 2 fold changes
above 4.3, and 25% were above 6.0. Greater than 50% of the genes up-regulated at 48 hours
were unchanged or undetected at any other timepoint. Similar to box and whisker plots, violin
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plots (Figure 9B) represent the distribution of sDEGs at each timepoint. Distribution of
positive/negative sDEGs is fairly consistent at 8 and 12 hours, a smaller range of sDEGS is
present at 24 hours, and 48 hours is skewed toward higher positive fold changes at as
compared to other timepoints. Early time points (8, 12h) indicate that there is many “on/off”
type behavior of genes with smaller fold changes. However, by 48h we see a large population of
genes that were not expressed at any previous timepoint and at much larger fold changes. This
pattern could indicate that genes required for Muller glia fate must be turned off concurrently
with genes required for dedifferentiation being turned on before genes required for RPC fate
can later be activated.

2.3.3 Pathway Analysis of Differentially Expressed Genes

In total, there were 1050 unique sDEGs when all timepoints were combined. This list was
analyzed using Reactome pathway analysis in order to understand which biological processes in
Rattus norvegicus are involved (Figure 10A). Signal transduction was the biological process
identified the most in this analysis with 120 genes found to be involved in these pathways.
Genes involved in signaling by TGF-β, Notch, Wnt, MAPK, Hippo, and Hedgehog pathways were
identified in the sDEGs analyzed. These pathways are all known to be involved in retinal
regeneration in vertebrates like zebrafish and chick (Meyers, et al., 2012; Wan, et al., 2016;
Tackenberg, et al., 2009; Hayes, et al., 2007; Yao, et al., 2016). 25 genes involved in
developmental pathways were identified, the majority of which pertained to pathways in
nervous system development, in addition to some involved in nervous system function. Genes
involved in early development were particularly relevant as fully differentiated Müller glia
should not typically exhibit characteristics of development. 14 genes involved in mitosis were
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identified, as well as genes involved in G1/S DNA damage checkpoints. Though the analysis was
performed on RNA extracted from mitotically active cell lines, normalization of values
compared to the control condition would account for genes involved in immortalization.
Metabolism was another area identified frequently in this analysis. Genes involved in metabolic
processes such as protein synthesis, regulation of insulin-like growth factor (IGF) transport, RNA
processing, and integration of energy metabolism were identified. Genes involved in chromatin
modification, gene silencing, and protein localization were also identified. A large immune
response was also detected through Reactome pathway analysis, including significant
expression changes of inflammatory genes like macrophage expressed 1 (mpeg1) and cytokine
expressed Csf1R and (Huang, et al., 2013; Mitchell, et al., 2018) . In zebrafish, acute
inflammation occurs in the damaged tissue and is known to promote dedifferentiation and
neurogenic proliferation in response to injury in the retina (Silva, et al., 2020). Also,
upregulation of zebrafish Müller-derived progenitor cell factor Mmp9 is shown to be recruited
in response to inflammation in photoreceptor damage (Silva, et al., 2020).
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Figure 10. Pathway Analysis of Differentially Expressed Genes (A) Reactome map display of the distribution of
biological processes in which significant differentially expressed genes identified via mRNA sequencing of
timepoints listed in figure 9 are involved in rat. (B) Distribution of total significantly expressed genes 8, 12, 24 and
48-hours post exposure to PNU-282987 treated RPE supernatant compared to DMSO control. (B’) sDEGs which
were only found to be significant at the corresponding timepoint. (B’’) Percent of sDEGs which were unique to a
timepoint compared to the total number at that timepoint.

Many DEGs were found to be significant across multiple timepoints. Figure 10B shows
the number of sDEGs at each timepoint (B), as well as the number (B’) and percent (B’’) of those
genes which were unique at each timepoint. At 8 hours post treatment, 81.2% of genes were
significant when compared to another timepoint. The 8 hour timepoint shared 80.7% sDEGs of
all with the 12 hour timepoint, and only 2.2% with the 24 hour timepoint and 3.9% with the 48
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hour timepoint. At 12 hours post treatment, 80% of genes were significant at another
timepoint. The 12 hour timepoint shared 78.6% sDEGs with the 8 hour timepoint, 2.8% with the
24 hour timepoint, and 3.8% with the 48 hour timepoint. 24 hours post treatment, only 13.6%
of significant genes were significant at another timepoint. The 24 hour timepoint shared 3.3%
of sDEGs with the 8 hour timepoint, 4.4% with the 12 hour timepoint, and 9.1% with 48 hours.
At 48 hours post treatment, 12.6% of genes were significant at another timepoint. The 48 hour
timepoint shared 4.8% sDEGs with the 8 hour timepoint, as well as 4.8% for the 12 hour
timepoint, and 7.5% at 24 hours. Overall, the 24 and 48 hour timepoints had a more unique
transcript profile than the other conditions. In vivo, these two timepoints produced the maximal
number of BrdU+ cells following PNU-282987 treatment and was the time when retinal
progenitor markers began to be expressed (Webster, et al., 2017; Webster, et al., 2019). The
patterns of gene expression changes in these data are consistent with what we would expect in
a system where inhibitors of proliferation are deactivated and proliferative genes are activated,
followed by production of Müller derived progenitor cells.

To understand how the up- and down-regulation of these genes may contribute to
dedifferentiation of the Müller glia, known pathways of retinal regeneration in zebrafish and
chick, as well as those known to be involved in development of the mammalian retina were
compared to the results obtained from RNA-seq results (Table 3). Table 3A shows genes at the 8
hour timepoint with up- or down-regulations in expression compared to control of genes
identified in literature on retinal regeneration. Up-regulation of β-catenin, a co-transcriptional
regulator in the Wnt/β-Catenin pathway of proliferation (Gallina, et al., 2016), HB-EGF, a ligand
known to initiate retinal regeneration in zebrafish (Wan, et al., 2012), and Mmp9, an activator
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of Wnt signaling through the Hedgehog pathway of retinal regeneration in chick (Kaur, et al.,
2018) was observed at 8 hours. Down-regulation of Bmp4, a transcription factor associated with
adult Müller cell identity as well as down-regulation of Wnt inhibitors such as transcription
factor Dkk3, MicroRNA Let7d and hedgehog transcription factor Gli3 are observed at 8 hours as
well (Nakamura, et al., 2007; Kaur, et al., 2018). Table 3B shows changes in up- and
downregulation of molecules identified through RNA sequencing at 12 hours which are related
to regeneration of the retina. The 12 hour timepoint was very similar to the 8 hour timepoint,
with up-regulation of β-catenin, HB-EGF, and Mmp9, as well as down-regulation of Dkk3. In
addition,
Fzd9, a frizzled receptor which Wnt ligands bind (Lenkowski, et al., 2014), was up-regulated at
12 hours, which could point to an increase in Wnt signaling at this time. Retinal progenitor
markers Vsx2 and Nestin (Wright, et al., 2010; Lee, et al., 2012) were also up-regulated at 12
hours. Table 3C shows sDEGs at 24 hours compared to literature on retinal regeneration. At this
timepoint, up-regulation of Ascl1 occurs. Ascl1 is transcription factor downstream of HB-EGF
which, along with co-transcriptional regulator Lin28a, activates Wnt signaling in zebrafish
regeneration (Wan, et al., 2012). Up-regulation of retinal progenitor marker Sox9 also occurs at
24 hours (Poché, et al., 2008). Table 3D highlights molecules identified in literature to be
important at 48 hours, including up-regulation of Ascl1 again as well as Lin28a, Ascl1 recruiters
Pou3f2 and Myt1 (Chanda, et al., 2014), and retinal progenitor marker Sox9. Fibroblast growth
factors Fgf9 and Fgf11 are up-regulated at this time. Fgf genes are involved in the proliferation
of the Müller glia in the zebrafish and chick retina (Fischer, et al., 2002; Wan, et al. 2017) and
have been shown to be regulators of Wnt signaling (Tang, et al., 2019). Volcano plots (Figure
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11) represent a distribution of the log2 fold changes seen at each timepoint. The black points
represent differentially expressed genes, whereas blue points are those which were
significantly up-regulated and red were significantly down-regulated. The volcano plots for 8
and 12 hours show a consistent distribution of both significantly up- and down-regulated genes.
The plot for 24 hours shows fewer significant genes overall, with many genes showing a
similarity in expression. The 48 hour plot shows a striking disparity between up- and
downregulated differentially expressed genes, with the majority being up-regulated and to a
higher degree than what is seen at other timepoints. These data overall point to up-regulation
of genes early on which are related to proliferation and dedifferentiation of Müller glia and
downregulation of genes known to prevent proliferation. In later timepoints, up-regulation of
genes associated with asymmetrical division of Müller glia to produce cells with a retinal
progenitor-like fate occurs.
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Table 3. Molecules of interest in Müller glia dedifferentiation. Table 3 (A-D) lists log2 Fold Changes of RNA extracted
from treated Müller glia.
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Figure 11. Volcano plots of sDEGs at 8 hours vs control (A) =, 12 hours vs control (B), 24 hours vs control (C) and 48
hours vs control (D). Plots represent all DEGs as dots based on their fold change, with down-regulated sDEGS in
blue and up-regulated sDEGs in red.
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2.3.4 qRT-PCR Confirmation of Differentially Expressed Genes

Figure 12 summarizes experiments in which qRT-PCR was performed to validate RNA
sequencing results for certain molecules of interest thought to be involved in dedifferentiation
pathways. qRT-PCR verification was performed using the SuperScript™ III Platinum™ One-Step
qRT-PCR Kit with ROX (11745500, ThermoFisher Scientific) on RNA extracted from Müller glia at
each timepoint condition plus the DMSO control, as described previously. Each sample was run
in triplicate in each assay and each assay was repeated in triplicate. Results of the qRT-PCR data
were analyzed with the comparative Ct method (2-ΔΔCT), and normalized to Gapdh, used as a
housekeeping gene. RNA Sequencing data and qRT-PCR data are displayed for factors at
differing treatment timepoints (Figure 12).
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Figure 12 (A) RNA-seq results of molecules of interest identified in literature to be involved in regeneration of the
ΔΔCT)
zebrafish and chick retina and mammalian retinal development. (B) Fold change [2 (] results of qPCR
verification of molecules of interest in A.
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Bmp4, a protein coding gene in the TGFβ family, known to be down-regulated in chick
Müller-derived progenitor cells (Todd, et al., 2017), is found to be down-regulated at 8 hours in
RNAseq results as well as all other timepoints in qRT-PCR. HB-EGF, found to be up-regulated at
8 and 12 hours in RNA seq results, was confirmed to follow the same trend via qRT-PCR, as well
as qRT-PCR confirmation of Ascl1 and Lin28a up-regulation at 48 hours and 24/48 hours,
respectively. These finding are consistent with the pathway of retinal regeneration in zebrafish
in which HB-EGF activation at the site of injury leads to the activation of Ascl1 to then recruit
Lin28a (Wan, et al., 2012; Wan, et al., 2016; Ramachandran, et al., 2011). Bcat1 and Fzd9,
upregulated at 8 and 12 hours, and Fgf9/Fgf11, up-regulated at 48 hours in RNA seq, followed
the same trend in qRT-PCR verification. Fzd9 is a receptor which binds Wnt ligands (Meyers, et
al., 2012; Tappeiner, et al., 2016; Wan, et al., 2012). Fgf9 and Fgf11 are up-regulated in
Müllerderived progenitor cells in other vertebrates (Fischer, et al., 2002; Hochmann, et al.,
2012; Wan, et al., 2017). Mmp9 and Gli3, components of the sonic hedgehog (Shh) pathway
that are up- and down-regulated respectively early in zebrafish regeneration (Wan, et al., 2016;
Kaur, et al., 2018) were up- and down-regulated at 8 and 12 hours in RNA-seq, confirmed in
qRT-PCR. Finally, retinal progenitor marker Sox9 (Webster, et al., 2017) (Young, 1985) was upregulated at 24 and 48 hours, which is confirmed in qRT-PCR results. These data provide
evidence to support findings in the RNA sequencing results.
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Figure 13. BAM changes in HB-EGF, Ascl1, and Lin28a. (A) Changes in exon and intron hits on HB-EGF gene of RNA
from DMSO control, 8-hour and 12-hour timepoint. (B) Increase in exon and intron hits in Ascl1 at 24 hours
compared to DMSO control. (C) Increase in exon and intron hits in Lin28a at 48-hours compared to control.
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2.3.5 Transcriptional Variation in Treated Müller glia

Binary Alignment Sequence Maps (BAMs) provide a visualization of the comprehensive
raw data in mRNA sequencing (Raplee, et al., 2019). In this study, GeneWiz® used STAR aligner,
a splice aligner that detects splice junctions and incorporates them to help align entire read
sequences, to visualize changes in exon splicing and genome hits based on the RNA for all four
conditions plus the control. HB-EGF, up-regulated in RNA-seq and qRT-PCR at 8 and 12 hours,
showed an increase in both exon and intron hits, as well as new locations of exon and intron
hits on the gene locus at 8 and 12 hours compared to control. Ascl1, up-regulated at 24 and 48
hours, showed an up-regulation of exon hits at 24 and 48 hours. Lin28a, up-regulated at 48
hours showed an increase in exon and intron hits as well as new intron hits at 48 hours. These
data provide evidence that variations in transcriptional activity are occurring in genes HB-EGF,
Ascl1, and Lin28a following exposure to PNU-282987 treated RPE. Figure 13 shows a
visualization of the BAMS for HB-EGF (A) at 8 and 12 hours compared to control, Ascl1 (B) at 24
and 48 hours compared to control, and Lin28a (C) at 48 hours compared to control.

2.3.6 Dedifferentiation of Müller Glia to Retinal Progenitor Cells
To provide evidence that retinal progenitor cells were produced as a result of treatment with
supernatant from cultured RPE cells (Webster, et al., 2017), ICC was performed to identify
retinal progenitor cell markers in Müller glia cultures following a 48-hour exposure to
PNU282987 treated RPE. In these studies, RPE were incubated in normal media for 72 hours
following 24-hour PNU-282987 treatment and extensive rinsing. The supernatant from the
cultured RPE cells was then transferred to a culture dish containing Müller glia for 48 hours.
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Following incubation with the supernatant, cells were fixed and processed with antibodies
against vimentin, VSX2, nestin and OTX2 (Figure 14).

Figure 14. Immunocytochemistry of Müller glia after 48-hour exposure to PNU-282987 treated RPE supernatant.
Scale bars represent 100 microns. (A, A’) Müller glial cytoskeletal component, Vimentin, used as a control in DMSO
and PNU-282987 treated rMC-1. (B, B’) Retinal progenitor marker VSX2 is identified in treated Müller glia. Arrows
indicate VSX2+ single nuclei. (C, C’) Retinal progenitor marker Nestin labels cytoskeleton of treated Müller glia.
Arrows indicate single Nestin+ cells. (D, D’) Transcription factor OTX2 labels both nucleus and cytoskeleton of
treated Müller glia. Arrows indicate OTX2+ cells. Scale bar represents 100 microns. (E) Quantification of cells
positive for progenitor markers. A one-way ANOVA was performed to determine statistical significance. All three
progenitor cell markers were found to be statistically significant when compared to DMSO controls (P-value
<0.001, ***) in PNU-282987 treated cells.
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Vimentin, a Müller glia marker found in the unaltered adult retina (Tackenberg, et al.,
2009), was used as a control (Figure 14A, A’). An antibody against Nestin, used to stain neural
precursor cells in the developing retina (Božanić, et al., 2006) labeled Müller glia exposed to
PNU-282987 treated RPE supernatant but did not label control untreated cells (figure 14B, B’). A
second retinal progenitor marker, VSX2, found in prenatal eye cultures in neurospheres with
neurogenic potential (Wright, et al., 2010), immunostained supernatant-treated Müller glia,
but not in control cells (figure 14C, C’). Finally, OTX2, another retinal progenitor marker widely
accepted to represent stem-like qualities in the developing retina (Schmitt, et al., 2009),
immunostained treated Müller glia but not untreated cells (figure 14D, D’). All cells were
counterstained with Hoescht (1:13,000) to label nuclei. Quantification of areas per
experimental progenitor labeled culture was performed. In the PNU-282987 condition
immunostained for VSX2, 49.17% (SD +/- 0.123) of cells were VSX2+. In the PNU-282987
condition immunostained for Nestin, 54.94% (SD +/- 0.113) of cells were Nestin+. In the
PNU282987 condition immunostained for OTX2, 55.23% (SD +/- 0.125) of cells were OTX2+
(Figure 14E). All control markers had zero positive cells. A one-way ANOVA was performed to
determine statistical significance from the total number of cells cultured. All three markers
were found to be statistically significant (P-value <0.001) in PNU-282987 treated cells. Müller
cells with positive staining for retinal progenitor markers provide evidence that Müller glia are
dedifferentiating to a progenitor-like fate.
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2.3.7 Summary of sDEGs involved in Dedifferentiation of Müller Glia to MDPCs
Based on these findings as well as results from previous studies, a potential pathway of
molecules involved in the dedifferentiation of Müller glia to Müller-derived progenitor cells
(MDPCs) following administration of PNU-282987 treated RPE supernatant was generated and
is outlined in Figure 15. HB-EGF is the early initiator of the pathway, leading to the activation of
Ascl1 and Lin28a, which allow for the β-catenin/Wnt pathway to turn on, activating Fgf11/Fgf9
as well as Wnt receptor Fzd9. Let7 inhibition occurs via activation of Mmp9 and inhibition of
Gli3, driving forward the Wnt pathway. Wnt inhibitor Dkk3 is also down-regulated, which allows
the Wnt/β-catenin pathway to produce MDPCs, characterized by retinal progenitor markers
Sox9, Nestin, OTX2 and VSX2.
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Figure 15. Summary of gene expression associated with dedifferentiation of Müller glia to Müller-derived
progenitor cells in adult mammals. HB-EGF is up-regulated when Müller glia are exposed to RPE supernatant
treated with PNU-282987. HB-EGF activates Ascl1, which then activates Lin28a, leading Müller glia to diverge from
their adult identity. Lin28a activates the Wnt/β-catenin signaling pathway to induce cell proliferation. Dkk3 is
inhibited to prevent the inhibition of the Wnt/β-catenin pathway. Wnt ligands bind Fzd9, activating Wnt signaling.
Fgf11/Fgf9 signaling, along with Wnt, leads to cell proliferation in the Müller glia. Let-7 is inhibited by Mmp9
activation and Gli3 inhibition to allow for Müller glial proliferation. Cell proliferation from the Wnt/β-catenin
pathway and other pathways leads to the production of Müller-derived progenitor cells, characterized by retinal
progenitor markers Sox9, Nestin, VSX2 and OTX2.

2.4 Discussion
2.4.1 Summary

In this study, we show that activated RPE supernatant initiates transcriptional changes
in Müller glia that lead to gene expression profiles resembling that of dedifferentiated Müller
glia and MDPCs including activation of the HB-EGF/Ascl1/Lin28a pathway. In culture, we find
evidence of retinal progenitor-like cells following exposure to activated RPE supernatant.
Previous studies in zebrafish have demonstrated many pathways involved in Müller glial
dedifferentiation and retinal regeneration that also appear to be involved in PNU282987induced dedifferentiation of Müller glia in adult mice. HB-EGF is also shown to be upregulated at the injury site in zebrafish, leading to activation of Ascl1 followed by Lin28a which
stimulates the formation of multipotent Müller derived progenitor cells in the retina (Wan, et
al., 2012; 2016). HB-EGF activation leads to Wnt/β-Catenin signaling in zebrafish, the pathway
which allows for cell proliferation in the zebrafish retina (Gallina, et al., 2016; Wan, et al., 2016).
Fzd9 is a Wnt receptor known to be activated in the HB-EGF/Ascl1 pathway by Wnt ligands
(Ramachandran, et al., 2011; Gallina, et al., 2016). Wnt signaling occurs in the development of
retinal progenitor cells (Meyers, et al., 2012). Let-7 microRNA, a repressor of retinal
regeneration-associated genes in zebrafish such as Ascl1, oct4 and myc, is inhibited during
retinal regeneration in zebrafish (Ramachandran, et al., 2010). Let-7 is a regulator of sonic
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hedgehog (Shh) signaling (Locker, et al., 2006) and is a marker for differentiation from retinal
progenitor to adult cell in the developing retina (Xia, et al., 2016). Shh component Mmp9 is
found in injured retinal cells prior to progenitor cell markers and regulates Ascl1. Shh
component Gli3 is a negative regulator of Ascl1 and is reduced in Müller glia progenitor cells
(Kaur, et al., 2018). Under normal physiological conditions, Gli3 physically interacts with the
Ascl1 promotor to inhibit its expression (Kaur, et al., 2018). Down-regulation of this molecule
allows the Ascl1 pathway to move forward and Müller glia to dedifferentiate into multipotent
progenitor cells.

The RNA-seq data reported in this current study showed many similarities to this zebrafish
pathway (Table 3). Up-regulation of HB-EGF was found at 8 and 12 hours, followed by upregulation of Ascl1 at 24 and 48 hours and Lin28a at 48 hours. HB-EGF is also known to act
upstream of β-Catenin signaling (Wan, et al., 2012). The β-catenin/Wnt pathway is essential in
the production of Müller-derived progenitor cells in chick (Gallina, et al., 2016) and in eye
development (Fujimura, 2016). Bcat1 is up-regulated at 8 and 12 hours according to sequencing
data, as well as 24 and 48 hours in qRT-PCR data. Dkk3, an inhibitor of the Wnt pathway found
in adult mammalian Müller glia (Nakamura, et al., 2007), is down-regulated at both 8 and 12
hours in our data. Retinal progenitor marker Sox9 is up-regulated at 48 hours.

Given that Müller glia dedifferentiate and proliferate before production of MDPCs in
other models, it is expected that progenitor cell markers would appear at later timepoints.
Expression of markers found in multipotent mouse progenitor cells during retinogenesis
appeared at 24 and 48 hours (Sox9, Vsx1, Nestin). We see down-regulation at 8 and 12 hours of
markers associated with fully differentiated Müller glia (Todd, et al., 2017) (Bmp4), as well as
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inhibitors of cell cycle re-entry (Hes4, Hes6, Gli3, Let-7). Molecules known to be precursors of
Müller glia dedifferentiation in adult zebrafish (HB-EGF, Mmp9) are up-regulated at 8 and 12
hours after treatment with RPE supernatant. Likewise, our data shows significant
downregulation of Gli3 and Let-7 at 8 hours as well as Let-7 at 12 hours (Table 3).
Fzd9, a Wnt receptor known to be activated in the HB-EGF/Ascl1 pathway
(Ramachandran, et al., 2011), is up-regulated at 12 hours with qPCR confirmation. Let-7
microRNA is both a repressor of retinal regeneration-associated genes in zebrafish and a
regulator of sonic hedgehog (Shh) signaling (Locker, et al., 2006). Down-regulation of Let-7 is
observed at 8 hours as well as Let-7 at 12 hours. Sonic hedgehog (Shh) components Mmp9 and
Gli3, are positive and negative regulators, respectively, of progenitor proliferation in chick
(Kaur, et al., 2018). Our data show up-regulation of Mmp9 at 8 and 12 hours, and
downregulation of Gli3 and Let-7 at 8 hours. In addition, Table 3 illustrates up-regulation of
fibroblast growth factors Fgf9 and Fgf11 at 48 hours following treatment. These factors are
regulators of the MAPK signaling cascade of Müller glia proliferation, activated by HB-EGF in
zebrafish (Fischer, et al., 2002; McCabe, et al., 2006; Wan, et al., 2017).
In addition, fibroblast growth factors are upstream regulators of the MAPK signaling
cascade which is activated by HB-EGF (McCabe, et al., 2008). Fgf9 and Fgf11 are released by
retinal cells in Xenopus to initiate dedifferentiation and reprogramming (Fukui, et al., 2012;
Meyers, et al., 2012). FGFR signaling also promotes retinal regeneration in chick and zebrafish
(Gallina, et al., 2016; Fujimura, 2016). Wnt inhibitor Dkk3 is produced under normal
physiological conditions in the Müller glia. Inhibition of Dkk3 allows the Wnt/β-catenin pathway
to produce Müller-derived progenitor cells (Nakamura, et al., 2007; Fujimura, 2016),
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characterized by retinal progenitors Sox9, Nestin, OTX2 and VSX2 (Koike, et al., 2007; Schmitt,
et al., 2009; Wright, et al., 2010; Webster, et al., 2019).
Based on the results from this study as well as results from previous literature, a
summary of gene activation that occurs in Müller glia after treatment with RPE supernatant
exposure has been proposed. HB-EGF, an EGFR ligand (8, 12 hour up-regulation), is known to
work upstream of Ascl1 (24, 48 hour up-regulation), a basic helix-loop-helix transcription factor,
which then activates RNA binding protein Lin28a (48 hour up-regulation) to allow for
dedifferentiation in the zebrafish retina (Jin Wan, 2013). MicroRNA Let-7 (Down-regulation at 8
and 12 hours) is shown to inhibit dedifferentiation in the Müller glia in the adult zebrafish prior
to injury (Kaur, et al., 2018; Wan, et al., 2012)). Mmp9 (8, 12-hour up-regulation) regulates
Ascl1 and is found early in dedifferentiation (Locker, et al., 2006). Also, Mmp9 along with Gli3
are Shh pathway regulators of Let-7 in zebrafish regeneration (Wan, et al., 2016) (Kaur, et al.,
2018) Fzd9 (12 hour up-regulation) is a Wnt receptor known to be activated in HB-EGF/Ascl1
signaling (Ramachandran, et al., 2011). Finally, Βcat1 signaling (Up-regulated at 8 and 12 hours,
later in qPCR data) is both required in dedifferentiation to and maintenance of retinal
progenitors produced in zebrafish (Meyers, et al., 2012). β-Catenin also binds to Lin28a
promotor to activate transcription (Yao, 2016). Wnt/β-catenin signaling is the pathway that
drives the production of Müller-derived progenitor cells in chick (Gallina, et al., 2016) as well as
vertebrate eye development (Fujimura, 2016). Retinal progenitor marker Sox9 (up-regulated at
24 and 48 hours) as well as progenitor markers Nestin, OTX2 and VSX2, identified in ICC,
provides evidence of an MDPC-like fate.
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However, the use of immortalized cell lines in this study could be viewed as a limitation
for these studies. Immortalization is by definition an alteration of the genome of cells away
from normal physiological conditions. However, results were normalized to the control
condition. Therefore, all changes in gene expression were relative to the control in both cell
lines. A standard quantity of RNA was used as well to normalize the comparative responses.
Future studies will repeat these experiments in primary RPE and Müller glial cells to validate
these findings.

2.4.2 Implications
The neurogenic response to injury in the retina is common in lower vertebrates, such as
teleost fish and chick (Stenkamp, 2015). Currently, the adult mammalian neuronal retina is not
thought to, under normal physiological conditions, have the ability to restore loss of function
cause by neuronal cell death past early development. However, this lab has found a robust
neurogenic response in the adult mammalian retina after eye drop application of PNU-282987
(Webster, et al., 2017; 2019) and the pathways involved in adult mice Müller glia
dedifferentiation have many similarities with regenerative pathways already studied in
zebrafish. Efforts to understand the mechanism by which this occurs will be useful in
understanding which factors limit the mammalian system from proliferating in adulthood and
how this can be manipulated to treat neurodegenerative diseases of various body systems,
including the retina.
The mechanism proposed as a result of this study could lead to the ability to control
dedifferentiation in an effort to restore vision in retinal neurodegenerative disease models. At
present, PNU-282987’s greatest effects would be in the retina, as it has been reported to inhibit
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a potassium channel in the heart if given systemically (Duris, et al., 2012; Deng, et al., 2019).
However, understanding the mechanism of PNU-282987’s effect in the retina could allow
bypassing the receptor to stimulate dedifferentiation through direct stimulation of the
pathways involved. Ultimately, it is crucial to address the function of the retina after α7 nAChR
agonist treatment. Even if new adult retinal neurons are generated after PNU-282987
treatment, one must ask if new cells make appropriate functional connections? Do they make
synapses and function to affect visual processing? Can regeneration of new neurons reverse the
functional effects of retinal disease, injury or age? One way to address these issues is to analyze
electroretinogram (ERG) activity in the rodent eye before and after α7 nAChR agonist treatment
with and without injury. These studies are currently underway.

The use of specific α7 nAChR agonists could potentially lead to important clinical
treatments for other neurodegenerative diseases in the eye as well as in the brain where α7
nACh receptors have been shown to be involved; such as Alzheimer’s, Parkinson’s and
Huntington’s diseases (Foucault-Fruchard, et al., 2017). α7 nAChRs within the subventricular
zone (SVZ), lining the lateral ventricle of the brain, have been found to be involved in
neurogenesis in the SVZ when activated (Mudo, et al., 2007; Narla, et al., 2013; Shabani, et al.,
2020). However, while PNU-282987 eye drops have been found to remain in the eye (Mata et
al., 2015), it is not suitable for systemic use as it can act to inhibit a potassium channel in the
heart (Duris, et al., 2012). As a result, understanding of the mechanism associated with cell
cycle reentry of Müller glia after exposure to RPE cells treated with PNU-282987 is crucial.
Understanding the genes and signaling pathways that are involved in this dedifferentiation
response may allow future treatments that directly stimulate proliferative pathways or genes to
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bypass the alpha7nAChR. For instance, the pathways identified in this study are known to act
in similar ways in other areas of the mammalian central nervous system. HB-EGF is widely
expressed in the brain, including the hippocampus and cerebral cortex, and is considered to
have multiple roles in the developing nervous system (Oyagi, et al., 2012). Canonical
Wnt/βcatenin signaling plays a big role in tissue patterning in regulating rostral-caudal and
mediallateral patterning in the developing cortex (Noelanders, et al., 2017). Flushing out the
mechanism by which neurogenesis is induced in the retina using PNU-282987 could allow for an
understanding of inducible neurogenesis in adult mammals in the CNS.
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Supplemental Table 1. Summary of efficiency curves of all primer/probes used in qRT-PCR. All RNA Integrity Number
(RIN) values for RNA used were greater than 6.0 and all efficiencies for primer/probes were between 90%110%.
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CHAPTER III

DISCUSSION

3.1 Summary

In this study, we performed RNA sequencing on Müller glia that were exposed to
supernatant from RPE cells treated with PNU-282987. Müller glia were exposed for 8, 12, 24
and 48 hours and one condition was treated with DMSO for 48 hours as a control. A total of
15,000 changes in gene expression were detected compared to control conditions. Statistical
analysis performed by Genewiz® revealed 1050 significant differentially expressed genes
(sDEGs) (P-value <0.05 and log2 fold change >1/<-1) across the four timepoints compared to the
control combined. Reactome pathway analysis of sDEGs revealed signaling molecules
associated with many signaling pathways, including pathways known to be involved in the
regeneration of the zebrafish retina (Wnt, HB-EGF, MAPK, Hippo, Hedgehog) (Gallina, et al.,
2016) (Kaur, et al., 2018) (Rueda, et al., 2019) (Wan, et al., 2012).

For instance, Wnt signaling pathways control a wide range of processes in vertebrates
including cell proliferation, cell fate decision, cell polarity and stem cell maintenance
(MacDonald, et al., 2009; Saito-Diaz, et al., 2013). Wnt family members have been identified in
mammals with distinct expression patterns during development (Willert, et al., 2012). The Wnt
pathway is classically divided into the canonical pathway and several non-canonical versions
which regulate different processes. The canonical pathway involves binding of Wnt ligands to
one of 10 Frizzled (FZD) receptors in conjunction with the LRP5/6 co-receptors to activate a
transcriptional cascade which controls cell fate, proliferation and self-renewal of stem cells
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(Saito-Diaz, et al., 2013). Binding FZD receptors by Wnt ligands results in the stabilization and
translocalization of β-catenin to the nucleus, where it is a co-activator for lymphoid enhancer
binding factor (LEF) and T cell factor (TEF) -dependent transcription (Saito-Diaz, et al., 2013).

Signaling upstream of Wnt in zebrafish regeneration involves the activation of heparin
binding epidermal like growth factor (HB-EGF) which is rapidly induced at the site of injury in
the zebrafish retina and is a upstream regulator of Mitogen activated protein kinases (MAPK)
signaling (Wan, et al., 2012). MAPKs are conserved serine/threonine kinases that, through
varied stimuli, activate processes including gene expression, metabolism, proliferation,
differentiation and apoptosis. HB-EGF in zebrafish has been found to be the initiating ligand of
retinal regeneration, igniting a signaling cascade which branches out to involve multiple
processes (Wan, et al., 2012). It is found to mediate its effects via an EGFR/MAPK signal
transduction cascade which regulates the expression of regeneration-associated genes (Beach,
et al., 2017). HB-EGF activates Ascl1, which has been shown to be sufficient in reprogramming
mammalian Müller glia in culture to retinal progenitor cells (Pollak, et al., 2013). Ascl1 then
activates Lin28a which is sufficient in producing MG proliferation in the uninjured mouse retina
(Yao, et al., 2016). Finally, HB-EGF has been shown to act upstream of Wnt/β-catenin signaling
cascade known to control progenitor cell proliferation from Müller glia (Wan, et al., 2012).

Hippo signaling is a network of reactions which regulates cell proliferation and apoptosis
in mammals required to prevent overgrowth and tumorigenesis under normal physiological
conditions. In this pathway, dsRNA and pre-miRNA cleaving enzyme Dicer is regulated by
protein co-factors YAP and TAZ. Let-7 is a downstream regulator of the pathway which has been
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shown to accumulate in knockdowns of YAP/TAZ (Chaulk, et al., 2014). Inhibition of Let-7 is
associated with cell cycle re-entry in the zebrafish retina (Kaur, et al., 2018).

In addition, Sonic Hedgehog (Shh) is a secreted morphogen that regulates
developmental processes in vertebrates such as neural tube patterning, cell growth and
differentiation (Hui, et al., 2011). One type of retinal regeneration in chick occurs from the
anterior margin of the eye, near the ciliary body (CB) and ciliary marginal zone (CMZ).
Regeneration from the CB/CMZ is the result of proliferating retinal progenitor cells. This type of
regeneration is stimulated by Fgf2, and inhibited when a Fgf2 antagonist is used, showing that
Shh-induced regeneration acts through the Fgf signaling pathway (Spence, et al., 2004). Shh
signaling is regulated by intracellular signaling precursors such a Lin28a, miRNA Let-7, hedgehog
(hh), smoothened (Smo), and patched1 (ptch1) transcription factors (Kaur, et al., 2018) . Gli3
upregulation is associated with inhibition of the Shh pathway that drives forward regeneration
in zebrafish (Kaur, et al., 2018). Matrix metalloproteinase, Mmp9, is involved in an Mmp9/Shh
feedback loop which drives forward Müller glia dedifferentiation to retinal progenitor cells
(Kaur, et al., 2018).

We show that Müller glia dedifferentiate to produce retinal progenitor cells via initiation
of the HB-EGF/Ascl1/Lin28a pathway. HB-EGF is shown to be up-regulated at the injury site in
zebrafish, leading to activation of Ascl1 followed by Lin28a which stimulates the formation of
multipotent Müller derived progenitor cells in the retina (Wan, et al., 2012; Wan, et al., 2016).
HB-EGF activation leading to Wnt/β-Catenin signaling in zebrafish, the pathway which allows for
cell proliferation in the zebrafish retina (Gallina, et al., 2016; Wan, et al., 2016). Fzd9 is a Wnt
receptor known to be activated in the HB-EGF/Ascl1 pathway (Rajesh Ramachandran, 2011;
73

Gallina, et al., 2016). Wnt signaling occurs in the development of retinal progenitor cells (Meyers
JR, 2012). Let-7 microRNA, a repressor of retinal regeneration-associated genes in zebrafish such
as Ascl1, oct4 and myc, has been shown to be inhibited during retinal regeneration in zebrafish
(Ramachandran, et al., 2010). Let-7 is a regulator of sonic hedgehog (Shh) signaling (Locker, et al.,
2006) and is a marker for differentiation from retinal progenitor to adult cell in the developing
retina (Ahmad, 2016). Shh component Mmp9 is found in injured retinal cells prior to progenitor
cell markers and regulates Ascl1. Shh component Gli3 is a negative regulator of Ascl1 and is
reduced in Müller glia progenitor cells (Kaur, et al., 2018). Under normal physiological conditions,
Gli3 physically interacts with the Ascl1 promotor to inhibit its expression (Kaur, et al., 2018).
Down-regulation of this molecule allows the Ascl1 pathway to move forward and Müller glia to
dedifferentiate into multipotent progenitor cells.

In addition, fibroblast growth factors are upstream regulators of the MAPK signaling
cascade which is activated by HB-EGF (McCabe, et al., 2008). Fgf9 and Fgf11 are released by
retinal cells in Xenopus to initiate dedifferentiation and reprogramming (Fukui, et al., 2012;
Meyers JR, 2012). FGFR signaling also promotes retinal regeneration in chick and zebrafish
(Fujimura, 2016; Gallina, et al., 2016). Wnt inhibitor Dkk3 is produced under normal
physiological conditions in the Müller glia. Inhibition of Dkk3 allows the Wnt/β-catenin pathway
to produce Müller-derived progenitor cells (Nakamura, et al., 2007; Fujimura, 2016),
characterized by retinal progenitors Sox9, Nestin, OTX2 and VSX2 (Koike, et al., 2007; Schmitt,
et al., 2009; Wright, et al., 2015; Webster, et al., 2019). Thus, many genes and signaling
pathways involved in the regeneration of nonmammalian retina were also found to be involved
in dedifferentiation of a mammalian Muller glia cell line.
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We verified molecules of interest using qRT-PCR under the same treatment conditions
as compared to control. RNA sequencing, while reliable, only provides a sample size of one.
qRT-PCR allowed us to use transcript from repeated treatment conditions to verify trends seen
in RNA sequencing to increase our biological replicated. We verified molecules HB-EGF, Ascl1,
Lin28a, Fgf11, Fgf9, Fzd9, β-catenin, Mmp9, Gli3, Bmp4, and Sox9. Consistent with RNA
sequencing, we saw up-regulation on HB-EGF, Fzd9, Mmp9, and β-catenin early only, followed
by later up-regulation of Ascl1, Lin28a, Fgf9, Fgf11 and Sox9. Consistently, Gli3 and Bmp4 were
down-regulated in qRT-PCR studies. This validates the findings cited in RNA sequencing results.
The ability of Müller glial cell lines to dedifferentiate in culture in response to PNU-282987
treated RPE cell line supernatant was verified using immunocytochemistry. In response to a 48
hour RPE supernatant exposure, retinal progenitor markers VSX2, Nestin and OTX2 were
identified through immunostaining. VSX2 is a homeodomain transcription factor in retinal
progenitor cells in early mouse retinal development involved in maintaining neurogenic
potential in the progenitor cell pool (Wright, et al., 2015). Nestin is a class IV intermediate
filament expressed in the early CNS first described in the neural tube and somites and has been
shown in retinal progenitor cells as well (Mayer, et al., 2003). Nestin immunoreactivity appears
in cell soma of dividing neural progenitor cells and their leading processes in retinas from
embryonic day (E)13 to E20 (Qiu, et al., 2007). Otx2 is a transcription factor characterized in
postnatal retinal progenitor cell differentiation (Koike, et al., 2007). Positive immunostaining of
these markers, along with markers identified in RNA sequencing, provide evidence that Müller
glia dedifferentiate in culture when exposed to supernatant from PNU-282987-treated RPE
cells, consistent with results seen in vivo (Webster, et al., 2019).
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3.2 Strengths and Limitations

Strengths of this study include the consistency of results found in RNA sequencing,
which were verified by qRT-PCR for pathway genes. For the qRT-PCR studies, three
experimental replicates were repeated as three biological replicates to produce an average of
nine trials. The times at which genes were up-regulated largely matches what is expected based
on the timeline of Müller glia dedifferentiation found in this lab from in vivo studies (Webster,
et al., 2017; 2019) as well as the timeline of de-diffferentation pathways in zebrafish and chick
(Mayer, et al., 2003; Koike, et al., 2007; Wright, et al., 2015; Wan, et al., 2016; Kaur, et al.,
2018).

The use of immortalized cell lines in this study could be viewed as a limitation. Both RPEJ
and rMC-1 cells were immortalized using simian virus 40 (SV40). Immortalization is by definition
an alteration of the genome of cells away from normal physiological conditions. Given that both
cell lines were immortalized using SV40 and results were normalized to the control condition.
Therefore, all changes in gene expression were relative to the control, also performed in cell
lines. A standard quantity of RNA was used as well to normalize the comparative responses.
Future studies will repeat these experiments in primary RPE and Müller glial cells to validate
findings.
In vivo, retinal progenitor cell markers are typically not identified until 72 hours post
PNU-282987 treatment (Webster, et al., 2019). The timeline in this study ended at 48 hours due
to the nature of culture systems being compromised if left too long without maintenance. In
vivo, PNU-282987 is administered via eyedrop and must diffuse to the retinal pigment
epithelium. It is estimated that the 24 hour difference in progenitor marker detection in culture
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is due to the administration of RPE supernatant being in direct contact with Müller glia upon
administration. Also, RNA sequencing identified up-regulation of genes for Nestin and Vsx2 at
12 hours, further validating the early response which occurs in the culture system vs. results in
vivo.

3.3 Implications

The implications of this study are vast and varied. Glaucoma a neurodegenerative
disease of the eye which leads to retinal cell death (Weinreb, et al., 2014), is a disease which
effects 70 million people worldwide, with 10% of those people rendered bilaterally blind
(Weinreb, et al., 2014). Today, it is the worldwide leader in vision loss that by current medical
standards is considered irreversible. Diagnosis is frequently delayed as it is typically
asymptomatic until damage to the retina has occurred. A population survey of Americans found
that only 10% to 50% of patients with glaucoma are aware that they have the disease (Weinreb,
et al., 2014). Failure to diagnose glaucoma early prevents any treatment from being effective as
current treatments only serve to prevent further damage from occurring (Velez-Montoya, et al.,
2013).
Current treatment of glaucoma is limited to decreasing interocular pressure (IOP) to
prevent further damage to the retina. However, decreasing intraocular pressure will not reverse
injury already inflicted on the retina. Some types of glaucoma, such as normal tension
glaucoma, does not involve increased intraocular pressure at all. Although an increase in IOP is
a risk factor, it is not considered the primary cause of glaucoma (Mallick, et al., 2016). The
administration of PNU-282987 as eyedrops to the adult mammalian eyes to produce new RGCs
could be developed into a clinical treatment which address damage that occurs due to retinal
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neurodegenerative diseases, unlike common current treatments which solely address
associated risk factors. This novel treatment could increase proliferation and could be used in
conjunction with treatments that decrease IOP. This is the first treatment of its kind with the
potential to reverse vision loss that has occurred as a result of a retinal neurodegenerative
disease and is therefore hugely clinically significant.
Neurogenic response to injury in the retina is common in lower vertebrates such as
teleost fish and chick. Zebrafish and chick are animal models with extensive literature on the
neurogenic response of the retina (Stenkamp, 2015). Currently, the adult mammalian neuronal
retina is not thought to proliferate past early development. However, results from this lab has
found a very robust neurogenic response in the adult mammalian retina (Webster, et al., 2017;
2019). Efforts to understand the mechanism by which this occurs will be useful in
understanding which factors limit the mammalian from proliferating in adulthood and how this
can be manipulated to treat neurodegenerative diseases of various body systems including the
retina.

The development of PNU-282987 could potentially be an important clinical treatment
for localized neurodegenerative diseases. Also, understanding of the mechanism associated
with cell cycle reentry of Müller glia after exposure to RPE cells treated with PNU-282987 could
be applied to other neuronal cell types in adult mammals which are not known to be
proliferative after development and result in permanent damage to various systems.
PNU282987 is an α7 nAChR agonist and α7 nACh receptors are thought to be involved with
other neurodegenerative diseases in the body as well. This includes diseases such as
Alzheimer’s, Parkinson’s and Huntington’s diseases (Foucault-Fruchard, et al., 2017). While
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PNU-282987 is safe to use in the eye due to systemic isolation of the eye via the blood brain
barrier, it was found by Pharmacia & Upjohn to be problematic systemically as it interacts with
a potassium channel in the heart leading to cardiac dysrhythmia and death.
This study is not limited to understanding the mechanism of action of PNU-282987 in
producing neurogenesis in the adult mammalian retina. Understanding the mechanism by
which PNU-282987 can induce proliferation of retinal progenitor cells to differentiate into other
cell types could lead to therapeutic treatments that target the same pathways without the use
of PNU-282987. Being that PNU-282987 is problematic when given systemically, bypassing the
use of this drug to directly stimulate pathways involved may prove to be beneficial.
Understanding the mechanism could allow it to be manipulated to have various therapeutic
effects.
This mechanism is not limited to retinal regeneration, either. The retinal is an extension
of the central nervous system and is an excellent model in which to study properties of the
central nervous system (London, et al., 2013). The pathways identified in this study are known
to act in similar ways in other areas of the mammalian central nervous system. HB-EGF is widely
expressed in the brain, including the hippocampus and cerebral cortex, and is considered to
multiple roles in the developing nervous system (Oyagi, et al., 2012). Canonical Wnt/β-catenin
signaling plays a big role in in tissue patterning in regulating rostral-caudal and medial-lateral
patterning in the developing cortex. Flushing out the mechanism by which neurogenesis is
induced in the retina using PNU-282987 could allow for an understanding of inducible
neurogenesis in adult mammals in other CNS systems, shifting the paradigm of mammalian
neurobiology and human medicine.
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3.4 Future Directions

There is much work left to be done to flush out the mechanism by which the
mammalian retina is undergoing neurogenesis with application of PNU-282987. Experiments
performed in cell lines in this study will be repeated in primary cells in the future to validate
that SV40 immortalization is not interfering with the mechanism at hand. The mechanisms
worked out from experiments in culture will be translated in vivo using gene editing and
introduction of known contributing factors such as HB-EGF. This will also allow cells to be
treated for an extended period of time without the maintenance required with immortalized
cell lines in an effort to produce new, differentiated neurons in vivo.

Also, current research is being performed to understand the changes in gene expression
occurring from administration of PNU-282987 in RPE cells. This understanding will shed light on
the signaling molecules which are being released from RPE and altering gene expression of
Müller glia to produce retinal progenitor cells. The combination of these studies will provide a
full mechanism from administration of PNU-282987 to retinal progenitor cell production in the
eye. Experiments may one day be performed to study the role of PNU-282987 or induction of
the provided mechanisms to produce regeneration in other areas of the central nervous
system. These future studies will shed light on the inhibition occurring in mammals under
normal physiological conditions which prevents regeneration from occurring in the retina and
the central nervous system as a whole.

The functional capacity of cell produced through this method is vital to understanding
the ability of mammalian dedifferentiation via this mechanism to produce meaningful
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restoration of the retina. Studies are currently ongoing in the lab using electrophysiology to
determine if neurogenesis is producing functional neurons by measuring synaptic activity in
new cells.

Given that the robust regenerative response seen following application of PNU-282987
to the mammalian eye is not produced by other α7 nicotinic acetylcholine agonists in this
model, it is hypothesized that the molecular structure of PNU-282987 alters sterics of the α7
nicotinic acetylcholine receptor in retinal pigment epithelial cells, leading to pathway initiation
not seen in typical binding of this receptor. Studies are ongoing in the lab to test this
hypothesis.
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